{"id":36090,"date":"2021-10-07T10:13:21","date_gmt":"2021-10-07T08:13:21","guid":{"rendered":"https:\/\/www.crct-inserm.fr\/v2\/?page_id=36090"},"modified":"2024-01-08T12:01:40","modified_gmt":"2024-01-08T11:01:40","slug":"rn-blood","status":"publish","type":"page","link":"https:\/\/www.crct-inserm.fr\/rn-blood\/","title":{"rendered":"R’N BLOOD"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”a00720d8-8e3f-4b20-83b7-6d54485f541c” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”694d3d5d-3e0a-4cd1-b2ba-4eea0d99d5b4″ background_image=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/11\/LL_XenoFabi072018_1D886RKHE_rate-27.5x.jpg” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”8292df69-9d3c-4423-ab4f-a4755f6c1135″ width_tablet=”85%” width_phone=”” width_last_edited=”on|phone” custom_padding_last_edited=”off|desktop” header_font_size_phone=”31px” global_colors_info=”{}”]<\/p>\n

\u00c9quipe
ST\u00c9PHANE PYRONNET & FABIENNE MEGGETTO<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ header_2_font=”Open Sans||||||||” global_colors_info=”{}”]<\/p>\n

R’n Blood : <\/span><\/strong><\/h2>\n

Biologie des ARN dans les Tumeurs H\u00e9matologiques<\/b><\/h2>\n

 <\/p>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” width=”50%” custom_padding=”23px|||||” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/LOGO-TOUCAN-Horizontal.png” title_text=”LOGO-TOUCAN-Horizontal” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font_size=”22px” custom_margin=”30px|||||” custom_padding=”||3px|||” global_colors_info=”{}”]Le laboratoire d\u2019Excellence Toulouse Cancer est un projet qui vise \u00e0 comprendre les m\u00e9canismes de r\u00e9sistance et de rechute dans les cancers.
\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2022\/09\/septembre-en-or-150×150.png” title_text=”septembre en or” _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”rgba(43,135,218,0) 50%|#f2efef 50%” background_color_gradient_start=”rgba(43,135,218,0)” background_color_gradient_start_position=”50%” background_color_gradient_end=”#f2efef” background_color_gradient_end_position=”0%” custom_padding=”0px|||||” global_colors_info=”{}”][et_pb_row disabled_on=”on|on|on” _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||0px|||” disabled=”on” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=FkQuawiGWUw” image_src=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/video.jpg” _builder_version=”4.16″ _module_preset=”default” width=”80%” module_alignment=”center” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”#f2efef” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

Les sp\u00e9cificit\u00e9s
<\/strong>de notre axe de recherche<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” custom_padding=”2px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Les \u00e9v\u00e9nements post-transcriptionnels touchant les ARN permettent de contr\u00f4ler l\u2019expression g\u00e9nique rapidement et \u00e0 moindre cout \u00e9nerg\u00e9tique pour la cellule. Ils sont particuli\u00e8rement sollicit\u00e9s lorsque les cellules sont soumises \u00e0 un environnement stress\u00e9, comme dans une tumeur maligne ou sous l\u2019effet de traitements anti-tumoraux. Ils peuvent alors contribuer aux processus d\u2019adaptation n\u00e9cessaires \u00e0 la transformation maligne et\/ou \u00e0 la r\u00e9sistance aux traitements.<\/p>\n

Dans une perspective clinique, par des approches combin\u00e9es de s\u00e9quen\u00e7age nouvelle g\u00e9n\u00e9ration et haut d\u00e9bit des ARN (\u00ab\u00a0bulk\u00a0\u00bb ou \u00ab\u00a0single-cell RNAseq\u00a0\u00bb) et d\u2019imagerie cellulaire et tissulaire, notre \u00e9quipe explore l\u2019ensemble du r\u00e9pertoire des ARN (ARNm codants et ARN r\u00e9gulateurs non codants incluant les miRNAs, lncRNAs et circRNAs) et son h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 au sein de la tumeur, dans les cohortes de patients atteints de tumeurs h\u00e9matologiques (leuc\u00e9mies aigu\u00ebs et lymphomes anaplasiques). L\u2019objectif est l\u2019identification de nouvelles cibles th\u00e9rapeutiques et\/ou de sensibilisation aux traitements existants.<\/p>\n

Sur un plan cognitif et m\u00e9canistique, l\u2019\u00e9quipe met ensuite en \u0153uvre les approches exp\u00e9rimentales mol\u00e9culaires (gain\/perte de fonction), cellulaires et in vivo<\/em> (mod\u00e8les g\u00e9n\u00e9tiques et avatars de tumeurs humaines ou PDX) permettant \u00e0 la fois la caract\u00e9risation fonctionnelle des cibles potentielles et la description de leurs m\u00e9canismes d\u2019action. En partenariat avec des industriels, la possibilit\u00e9 de les cibler par des mol\u00e9cules \u00e0 potentiel th\u00e9rapeutique est \u00e9galement explor\u00e9e.<\/p>\n

[\/et_pb_text][et_pb_divider disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px|22px|false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Traduction des ARNm<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

ARN non codants<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px|22px|false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

miARN<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

lncARN<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” custom_margin=”-30px|auto|-31px|auto||” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

circARN<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Stress du r\u00e9ticulum<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px|0px|15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Leuc\u00e9mie aigu\u00eb<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Lymphome T p\u00e9diatrique<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” custom_margin=”-30px|auto|-31px|auto||” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Oncogen\u00e8se<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

R\u00e9sistance aux traitements<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px|0px|15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Th\u00e9rapies cibl\u00e9es<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_orientation=”center” custom_margin=”||15px||false|false” custom_padding=”15px||15px||false|false” border_color_bottom=”#F19532″ border_width_left=”5px” border_color_left=”#F19532″ global_colors_info=”{}”]<\/p>\n

Biomarqueurs<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

DES PROJETS<\/strong>
\nDE RECHERCHE<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_blog fullwidth=”off” posts_number=”5″ include_categories=”279″ use_manual_excerpt=”off” show_more=”on” show_author=”off” show_date=”off” show_categories=”off” masonry_tile_background_color=”#f2efef” _builder_version=”4.16″ _module_preset=”default” header_level=”h3″ header_font=”|800|||||||” header_font_size=”20px” body_font_size=”20px” read_more_text_color=”#5EC7ED” read_more_font_size=”20px” read_more_line_height=”3em” background_enable_color=”off” border_width_all=”0px” global_colors_info=”{}”][\/et_pb_blog][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

LES FOCUS<\/strong>
\nDE L\u2019\u00c9QUIPE<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”#ffffff 50%|rgba(174,227,246,0) 50%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”#ffffff” background_color_gradient_start_position=”50%” background_color_gradient_end=”rgba(174,227,246,0)” background_color_gradient_end_position=”0%” background_image=”https:\/\/www.crct-inserm.fr\/wp-content\/uploads\/2021\/03\/Filets-bleu-actu.png” background_size=”contain” background_position=”bottom_center” custom_padding=”0px|||||” saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-4px||false|false” header_font_size_tablet=”” header_font_size_phone=”” header_font_size_last_edited=”on|desktop” header_2_font_size_tablet=”” header_2_font_size_phone=”” header_2_font_size_last_edited=”on|desktop” header_4_font_size_tablet=”” header_4_font_size_phone=”” header_4_font_size_last_edited=”on|desktop” global_colors_info=”{}”]<\/p>\n

D\u00e9couvrir<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”990″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” _builder_version=”4.16″ _module_preset=”412cf9f9-c22e-468d-92e3-f93d454642a9″ header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” body_font_size_tablet=”” body_font_size_phone=”18px” body_font_size_last_edited=”on|phone” border_color_all_image=”#ffffff” border_width_bottom_image=”15px” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-3px||false|false” global_colors_info=”{}”]<\/p>\n

Comprendre<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”1184,1216″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” show_image_tablet=”” show_image_phone=”” show_image_last_edited=”on|phone” disabled_on=”off|off|off” _builder_version=”4.19.0″ _module_preset=”default” header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” border_width_bottom_image=”15px” border_color_bottom_image=”#ffffff” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text disabled_on=”off|off|off” _builder_version=”4.16″ _module_preset=”4ae3b26e-eab0-4b6f-bd7b-05f173fca79b” custom_margin=”||-4px||false|false” global_colors_info=”{}”]<\/p>\n

Participer<\/h4>\n

[\/et_pb_text][et_pb_post_slider posts_number=”5″ include_categories=”1249,1319″ show_arrows=”off” use_manual_excerpt=”off” excerpt_length=”0″ show_meta=”off” image_placement=”top” use_bg_overlay=”off” use_text_overlay=”off” dot_nav_custom_color=”#5EC7ED” disabled_on=”off|off|off” _builder_version=”4.21.0″ _module_preset=”default” header_font=”Open Sans|600|||||||” header_text_color=”#5EC7ED” header_font_size=”20px” header_line_height=”1.2em” body_font=”Open Sans||||||||” body_text_align=”left” body_text_color=”#505659″ body_font_size=”18px” background_color=”#FFFFFF” custom_button=”on” button_text_size=”18px” button_bg_color=”#5EC7ED” button_border_width=”0px” button_border_radius=”0px” button_use_icon=”off” button_alignment=”center” button_custom_margin=”20px||0px||false|false” button_custom_padding=”10px|50px|10px|50px|true|true” custom_padding=”0px|||||” header_font_size_tablet=”” header_font_size_phone=”22px” header_font_size_last_edited=”on|phone” body_font_size_tablet=”” body_font_size_phone=”18px” body_font_size_last_edited=”on|phone” border_width_bottom_image=”15px” border_color_bottom_image=”#ffffff” text_shadow_style=”preset4″ text_shadow_vertical_length=”0em” global_colors_info=”{}”][\/et_pb_post_slider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ disabled_on=”off|off|off” _builder_version=”4.17.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.1″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

En live<\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][et_pb_code _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”]\n\n

\n\t\n \n
\n \n
\n

\n RnBlood_CRCT<\/span>\n <\/span>\n Suivre<\/span>\n \n <\/path><\/svg>68<\/span>\n <\/path><\/svg>59<\/span>\n <\/span>\n <\/p>\n

\n Official account of the research group \"RNA Biology in Hematologic Tumors\" at the Cancer Research Center of Toulouse @crctoncopole #noncodingRNA #hematology <\/p>\n <\/div>\n

\n
\n <\/path><\/svg> <\/div>\n \"RnbloodC\"\n <\/div>\n <\/a>\n<\/div>\n\n
\n \n
\n\n \n
\n
\n \n \"RnbloodC;\n <\/a>\n \n RnBlood_CRCT<\/a>\n @RnbloodC<\/a>\n \n \t\t ·<\/span>\n\t
\n 8 Sep 1700147622256730335<\/span><\/a>\n <\/div>\n <\/div>\n
\n <\/path><\/svg> <\/div>\n <\/div>\n\n
\n \t\t\t\t

Great team effort, can\u2019t wait to apply this technique to better understand #resistance in #lymphoma!<\/p>\n\t\t\t\t\t\t\n \n\t \n \n <\/div>\n \n\t\n

\n \n <\/path><\/g><\/svg> R\u00e9pondre sur Twitter 1700147622256730335<\/span>\n <\/a>\n\n \n <\/path><\/svg> Retweeter sur Twitter 1700147622256730335<\/span>\n 0<\/span>\n <\/a>\n\n \n <\/path><\/g><\/svg> J\u2019aime sur Twitter 1700147622256730335<\/span>\n 2<\/span>\n <\/a>\n\n \n Twitter<\/span>\n 1700147622256730335<\/span>\n <\/a>\n \n\t<\/div>\n\n\t<\/div>\n\n <\/div>\n\n Voir plus<\/span><\/a>\n\n<\/span>\n<\/div>\n[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”#f2efef” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

PRODUCTIONS SCIENTIFIQUES<\/strong><\/h2>\n

[\/et_pb_text][et_pb_divider _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_toggle title=”PUBLICATIONS 2024″ open=”on” open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.22.1″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2024<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2023″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.22.1″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2023<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5d838c22bafe3154310804eb108c6684%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22EEGFVUZY%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cortacero%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECortacero%2C%20K%26%23xE9%3Bvin%2C%20Brienne%20McKenzie%2C%20Sabina%20M%26%23xFC%3Bller%2C%20Roxana%20Khazen%2C%20Fanny%20Lafouresse%2C%20Ga%26%23xEB%3Blle%20Corsaut%2C%20Nathalie%20Van%20Acker%2C%20et%20al.%20%26%23x201C%3BEvolutionary%20Design%20of%20Explainable%20Algorithms%20for%20Biomedical%20Image%20Segmentation.%26%23x201D%3B%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2014%2C%20no.%201%20%28November%206%2C%202023%29%3A%207112.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-023-42664-x%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-023-42664-x%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evolutionary%20design%20of%20explainable%20algorithms%20for%20biomedical%20image%20segmentation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%5Cu00e9vin%22%2C%22lastName%22%3A%22Cortacero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brienne%22%2C%22lastName%22%3A%22McKenzie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Lafouresse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ga%5Cu00eblle%22%2C%22lastName%22%3A%22Corsaut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Van%20Acker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois-Xavier%22%2C%22lastName%22%3A%22Frenois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Vergier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%20G.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herv%5Cu00e9%22%2C%22lastName%22%3A%22Luga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oskar%22%2C%22lastName%22%3A%22Staufer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Dustin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Cussat-Blanc%22%7D%5D%2C%22abstractNote%22%3A%22An%20unresolved%20issue%20in%20contemporary%20biomedicine%20is%20the%20overwhelming%20number%20and%20diversity%20of%20complex%20images%20that%20require%20annotation%2C%20analysis%20and%20interpretation.%20Recent%20advances%20in%20Deep%20Learning%20have%20revolutionized%20the%20field%20of%20computer%20vision%2C%20creating%20algorithms%20that%20compete%20with%20human%20experts%20in%20image%20segmentation%20tasks.%20However%2C%20these%20frameworks%20require%20large%20human-annotated%20datasets%20for%20training%20and%20the%20resulting%20%5C%22black%20box%5C%22%20models%20are%20difficult%20to%20interpret.%20In%20this%20study%2C%20we%20introduce%20Kartezio%2C%20a%20modular%20Cartesian%20Genetic%20Programming-based%20computational%20strategy%20that%20generates%20fully%20transparent%20and%20easily%20interpretable%20image%20processing%20pipelines%20by%20iteratively%20assembling%20and%20parameterizing%20computer%20vision%20functions.%20The%20pipelines%20thus%20generated%20exhibit%20comparable%20precision%20to%20state-of-the-art%20Deep%20Learning%20approaches%20on%20instance%20segmentation%20tasks%2C%20while%20requiring%20drastically%20smaller%20training%20datasets.%20This%20Few-Shot%20Learning%20method%20confers%20tremendous%20flexibility%2C%20speed%2C%20and%20functionality%20to%20this%20approach.%20We%20then%20deploy%20Kartezio%20to%20solve%20a%20series%20of%20semantic%20and%20instance%20segmentation%20problems%2C%20and%20demonstrate%20its%20utility%20across%20diverse%20images%20ranging%20from%20multiplexed%20tissue%20histopathology%20images%20to%20high%20resolution%20microscopy%20images.%20While%20the%20flexibility%2C%20robustness%20and%20practical%20utility%20of%20Kartezio%20make%20this%20fully%20explicable%20evolutionary%20designer%20a%20potential%20game-changer%20in%20the%20field%20of%20biomedical%20image%20processing%2C%20Kartezio%20remains%20complementary%20and%20potentially%20auxiliary%20to%20mainstream%20Deep%20Learning%20approaches.%22%2C%22date%22%3A%222023-11-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-023-42664-x%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222024-01-08T10%3A53%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22YJTSSGAP%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brugi%5Cu00e8res%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBrugi%26%23xE8%3Bres%2C%20Laurence%2C%20Nathalie%20Cozic%2C%20Roch%20Houot%2C%20Charlotte%20Rigaud%2C%20David%20Sibon%2C%20Julia%20Arfi-Rouche%2C%20Pierre%20Bories%2C%20et%20al.%20%26%23x201C%3BEfficacy%20and%20Safety%20of%20Crizotinib%20in%20ALK-Positive%20Systemic%20Anaplastic%20Large-Cell%20Lymphoma%20in%20Children%2C%20Adolescents%2C%20and%20Adult%20Patients%3A%20Results%20of%20the%20French%20AcS%26%23xE9%3B-Crizotinib%20Trial.%26%23x201D%3B%20%3Ci%3EEuropean%20Journal%20of%20Cancer%20%28Oxford%2C%20England%3A%201990%29%3C%5C%2Fi%3E%20191%20%28July%2017%2C%202023%29%3A%20112984.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejca.2023.112984%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejca.2023.112984%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Efficacy%20and%20safety%20of%20crizotinib%20in%20ALK-positive%20systemic%20anaplastic%20large-cell%20lymphoma%20in%20children%2C%20adolescents%2C%20and%20adult%20patients%3A%20results%20of%20the%20French%20AcS%5Cu00e9-crizotinib%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Brugi%5Cu00e8res%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Cozic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roch%22%2C%22lastName%22%3A%22Houot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Rigaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Sibon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Arfi-Rouche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Bories%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20S.%22%2C%22lastName%22%3A%22Cottereau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Delmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22Ducassou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Garnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amaury%22%2C%22lastName%22%3A%22Leruste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Millot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Moalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Morschhauser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Nolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Pagnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Reguerre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Renaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Schmitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathieu%22%2C%22lastName%22%3A%22Simonin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Verschuur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Hoog%20Labouret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celine%22%2C%22lastName%22%3A%22Mahier%20Ait%20Oukhatar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Vassal%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20French%20phase%20II%20AcS%5Cu00e9-crizotinib%20trial%20aimed%20to%20evaluate%20the%20safety%20and%20efficacy%20of%20crizotinib%20in%20patients%20with%20ALK%2C%20ROS1%2C%20and%20MET-driven%20malignancies%2C%20including%20ALK-positive%5Cu00a0anaplastic%20large-cell%20lymphoma%20%28ALK%2B%20ALCL%29.%5CnMETHODS%3A%20ALK%2B%20ALCL%20patients%2012%20months%20or%20older%20with%20measurable%20disease%20and%20no%20standard%20care%20options%20available%20received%20crizotinib%20twice%20daily%20at%20165%5Cu00a0mg%5C%2Fm2%20in%20children%20and%20adolescents%20and%20250%5Cu00a0mg%20in%20adults.%20The%20primary%20end-point%20was%20the%20response%20rate%20at%208%20weeks.%5CnRESULTS%3A%20Twenty-eight%20patients%20were%20enroled%20between%20February%5Cu00a02014%20and%20March%202018.%20Three%20patients%5Cu00a0who%20were%5Cu00a0not%20treated%5Cu00a0were%20excluded%20from%20the%5Cu00a0analysis.%20The%20median%20age%20was%2019%20years.%20The%20median%20previous%20line%20of%20chemotherapy%20was%20two.%20In%20the%2024%20patients%20with%20an%5Cu00a0evaluable%20response%2C%20the%20response%20rate%20at%208%20weeks%20was%2067%25%20%2895%25%20CI%3A%5Cu00a047-82%25%29.%20All%20patients%20discontinued%20crizotinib%20after%20a%20median%20treatment%20duration%20of%203.7%20months%3A%20eight%5Cu00a0for%20progression%2C%20two%5Cu00a0for%20adverse%20events%20%28AEs%29%5Cu00a0related%20to%20prior%20treatments%2C%20and%2015%20by%20choice%2C%20including%20six%5Cu00a0for%20allogeneic%20stem-cell%20transplantation.%20The%20median%20follow-up%20was%2045%20months.%20Nine%20patients%20experienced%20an%20event%3A%20eight%20relapses%20%28seven%20after%20crizotinib%20discontinuation%20and%20one%20after%20dose%20reduction%29%2C%20and%20one%20died%20in%20complete%20remission.%20The%20median%20duration%20of%20response%20was%2043.3%20months%20%2895%25%20CI%3A%5Cu00a08.3-not%20reached%29.%20The%203-year%20progression-free%20and%20overall%20survival%20rates%20were%2040%25%5Cu00a0%2895%25%20CI%3A%5Cu00a023-59%25%29%20and%2063%25%5Cu00a0%2895%25%20CI%3A%5Cu00a043-79%25%29.%20Grade%203%20or%204%20treatment-related%20AEs%20occurred%20in%2032%25%20of%20patients.%5CnCONCLUSION%3A%20Crizotinib%20shows%20efficacy%20and%20an%20acceptable%20safety%20profile%20in%20ALK%2B%20ALCL%20relapsed%5C%2Frefractory%20patients.%20However%2C%20a%20large%20proportion%20of%20patients%20experience%20a%20relapse%20after%20crizotinib%20discontinuation.%20Future%20studies%20will%20assess%20if%20prolonged%20ALK%20inhibitor%20exposure%20has%20curative%20potential%20without%20consolidation.%22%2C%22date%22%3A%222023-07-17%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ejca.2023.112984%22%2C%22ISSN%22%3A%221879-0852%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-08-25T09%3A34%3A59Z%22%7D%7D%2C%7B%22key%22%3A%228H3DFFP8%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Legrand%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELegrand%2C%20M%26%23xE9%3Blanie%2C%20Daniel%20Pissaloux%2C%20Franck%20Tirode%2C%20Anne%20Tallet%2C%20Christine%20Collin%2C%20Paul-Louis%20Chantreau%2C%20Patricia%20Berthon%2C%20et%20al.%20%26%23x201C%3BSSTR2A%20Is%20a%20Diagnostic%20Marker%20of%20Trichogerminoma.%26%23x201D%3B%20%3Ci%3EJournal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology%3A%20JEADV%3C%5C%2Fi%3E%2C%20July%208%2C%202023.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjdv.19319%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjdv.19319%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SSTR2A%20is%20a%20diagnostic%20marker%20of%20trichogerminoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00e9lanie%22%2C%22lastName%22%3A%22Legrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Pissaloux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Tirode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Tallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Collin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul-Louis%22%2C%22lastName%22%3A%22Chantreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Berthon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Jullie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Sohier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Calonje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%5Cu0161tjan%22%2C%22lastName%22%3A%22Luzar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Moulonguet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keisuke%22%2C%22lastName%22%3A%22Goto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristof%22%2C%22lastName%22%3A%22Cokelaere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Balme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lydia%22%2C%22lastName%22%3A%22Deschamps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Macagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cribier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Battistella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22de%20la%20Fouchardi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibault%22%2C%22lastName%22%3A%22Kervarrec%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-07-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fjdv.19319%22%2C%22ISSN%22%3A%221468-3083%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-08-25T09%3A34%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22NXC8649Z%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fuchs%20et%20al.%22%2C%22parsedDate%22%3A%222023-07-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuchs%2C%20Steffen%2C%20Clara%20Dan%26%23xDF%3Bmann%2C%20Filippos%20Klironomos%2C%20Annika%20Winkler%2C%20J%26%23xF6%3Brg%20Fallmann%2C%20Louisa-Marie%20Kruetzfeldt%2C%20Annabell%20Szymansky%2C%20et%20al.%20%26%23x201C%3BDefining%20the%20Landscape%20of%20Circular%20RNAs%20in%20Neuroblastoma%20Unveils%20a%20Global%20Suppressive%20Function%20of%20MYCN.%26%23x201D%3B%20%3Ci%3ENature%20Communications%3C%5C%2Fi%3E%2014%2C%20no.%201%20%28July%204%2C%202023%29%3A%203936.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-023-38747-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-023-38747-4%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Defining%20the%20landscape%20of%20circular%20RNAs%20in%20neuroblastoma%20unveils%20a%20global%20suppressive%20function%20of%20MYCN%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steffen%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Dan%5Cu00dfmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filippos%22%2C%22lastName%22%3A%22Klironomos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annika%22%2C%22lastName%22%3A%22Winkler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00f6rg%22%2C%22lastName%22%3A%22Fallmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louisa-Marie%22%2C%22lastName%22%3A%22Kruetzfeldt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabell%22%2C%22lastName%22%3A%22Szymansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julian%22%2C%22lastName%22%3A%22Naderi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%20H.%22%2C%22lastName%22%3A%22Bernhart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Grunewald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Konstantin%22%2C%22lastName%22%3A%22Helmsauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elias%22%2C%22lastName%22%3A%22Rodriguez-Fos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marieluise%22%2C%22lastName%22%3A%22Kirchner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Mertins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Astrahantseff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christin%22%2C%22lastName%22%3A%22Suenkel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joern%22%2C%22lastName%22%3A%22Toedling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Remke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20F.%22%2C%22lastName%22%3A%22Stadler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Hundsdoerfer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hedwig%20E.%22%2C%22lastName%22%3A%22Deubzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annette%22%2C%22lastName%22%3A%22K%5Cu00fcnkele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Lang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00f6rg%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anton%20G.%22%2C%22lastName%22%3A%22Henssen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelika%22%2C%22lastName%22%3A%22Eggert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolaus%22%2C%22lastName%22%3A%22Rajewsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Falk%22%2C%22lastName%22%3A%22Hertwig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20H.%22%2C%22lastName%22%3A%22Schulte%22%7D%5D%2C%22abstractNote%22%3A%22Circular%20RNAs%20%28circRNAs%29%20are%20a%20regulatory%20RNA%20class.%20While%20cancer-driving%20functions%20have%20been%20identified%20for%20single%20circRNAs%2C%20how%20they%20modulate%20gene%20expression%20in%20cancer%20is%20not%20well%20understood.%20We%20investigate%20circRNA%20expression%20in%20the%20pediatric%20malignancy%2C%20neuroblastoma%2C%20through%20deep%20whole-transcriptome%20sequencing%20in%20104%20primary%20neuroblastomas%20covering%20all%20risk%20groups.%20We%20demonstrate%20that%20MYCN%20amplification%2C%20which%20defines%20a%20subset%20of%20high-risk%20cases%2C%20causes%20globally%20suppressed%20circRNA%20biogenesis%20directly%20dependent%20on%20the%20DHX9%20RNA%20helicase.%20We%20detect%20similar%20mechanisms%20in%20shaping%20circRNA%20expression%20in%20the%20pediatric%20cancer%20medulloblastoma%20implying%20a%20general%20MYCN%20effect.%20Comparisons%20to%20other%20cancers%20identify%2025%20circRNAs%20that%20are%20specifically%20upregulated%20in%20neuroblastoma%2C%20including%20circARID1A.%20Transcribed%20from%20the%20ARID1A%20tumor%20suppressor%20gene%2C%20circARID1A%20promotes%20cell%20growth%20and%20survival%2C%20mediated%20by%20direct%20interaction%20with%20the%20KHSRP%20RNA-binding%20protein.%20Our%20study%20highlights%20the%20importance%20of%20MYCN%20regulating%20circRNAs%20in%20cancer%20and%20identifies%20molecular%20mechanisms%2C%20which%20explain%20their%20contribution%20to%20neuroblastoma%20pathogenesis.%22%2C%22date%22%3A%222023-07-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-023-38747-4%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-07-10T09%3A23%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22PP7H9SH5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Scholaert%20et%20al.%22%2C%22parsedDate%22%3A%222023-06-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EScholaert%2C%20Manon%2C%20Raissa%20Houmadi%2C%20Jeremy%20Martin%2C%20Nadine%20Serhan%2C%20Marie%20Tauber%2C%20Emilie%20Braun%2C%20Lilian%20Basso%2C%20et%20al.%20%26%23x201C%3B3D%20Deconvolution%20of%20Human%20Skin%20Immune%20Architecture%20with%20Multiplex%20Annotated%20Tissue%20Imaging%20System.%26%23x201D%3B%20%3Ci%3EScience%20Advances%3C%5C%2Fi%3E%209%2C%20no.%2023%20%28June%209%2C%202023%29%3A%20eadf9491.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adf9491%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.adf9491%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%223D%20deconvolution%20of%20human%20skin%20immune%20architecture%20with%20Multiplex%20Annotated%20Tissue%20Imaging%20System%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Scholaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raissa%22%2C%22lastName%22%3A%22Houmadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Serhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tauber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Braun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lilian%22%2C%22lastName%22%3A%22Basso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Merle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Descargues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manuelle%22%2C%22lastName%22%3A%22Viguier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Lesort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beno%5Cu00eet%22%2C%22lastName%22%3A%22Chaput%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Kanitakis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Jullien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20Bulai%22%2C%22lastName%22%3A%22Livideanu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emeline%22%2C%22lastName%22%3A%22Pag%5Cu00e8s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Gaudenzio%22%7D%5D%2C%22abstractNote%22%3A%22Routine%20clinical%20assays%2C%20such%20as%20conventional%20immunohistochemistry%2C%20often%20fail%20to%20resolve%20the%20regional%20heterogeneity%20of%20complex%20inflammatory%20skin%20conditions.%20We%20introduce%20MANTIS%20%28Multiplex%20Annotated%20Tissue%20Imaging%20System%29%2C%20a%20flexible%20analytic%20pipeline%20compatible%20with%20routine%20practice%2C%20specifically%20designed%20for%20spatially%20resolved%20immune%20phenotyping%20of%20the%20skin%20in%20experimental%20or%20clinical%20samples.%20On%20the%20basis%20of%20phenotype%20attribution%20matrices%20coupled%20to%20%5Cu03b1-shape%20algorithms%2C%20MANTIS%20projects%20a%20representative%20digital%20immune%20landscape%20while%20enabling%20automated%20detection%20of%20major%20inflammatory%20clusters%20and%20concomitant%20single-cell%20data%20quantification%20of%20biomarkers.%20We%20observed%20that%20severe%20pathological%20lesions%20from%20systemic%20lupus%20erythematosus%2C%20Kawasaki%20syndrome%2C%20or%20COVID-19-associated%20skin%20manifestations%20share%20common%20quantitative%20immune%20features%20while%20displaying%20a%20nonrandom%20distribution%20of%20cells%20with%20the%20formation%20of%20disease-specific%20dermal%20immune%20structures.%20Given%20its%20accuracy%20and%20flexibility%2C%20MANTIS%20is%20designed%20to%20solve%20the%20spatial%20organization%20of%20complex%20immune%20environments%20to%20better%20apprehend%20the%20pathophysiology%20of%20skin%20manifestations.%22%2C%22date%22%3A%222023-06-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.adf9491%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-08-25T09%3A34%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22XQU6FASJ%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Beishuizen%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBeishuizen%2C%20Auke%2C%20Karin%20Mellgren%2C%20Mara%20Andr%26%23xE9%3Bs%2C%20Anne%20Auperin%2C%20Chris%20M.%20Bacon%2C%20Simon%20Bomken%2C%20G.%20A.%20Amos%20Burke%2C%20et%20al.%20%26%23x201C%3BImproving%20Outcomes%20of%20Childhood%20and%20Young%20Adult%20Non-Hodgkin%20Lymphoma%3A%2025%20Years%20of%20Research%20and%20Collaboration%20within%20the%20Framework%20of%20the%20European%20Intergroup%20for%20Childhood%20Non-Hodgkin%20Lymphoma.%26%23x201D%3B%20%3Ci%3EThe%20Lancet.%20Haematology%3C%5C%2Fi%3E%2010%2C%20no.%203%20%28March%202023%29%3A%20e213%26%23x2013%3B24.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3026%2822%2900374-X%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3026%2822%2900374-X%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Improving%20outcomes%20of%20childhood%20and%20young%20adult%20non-Hodgkin%20lymphoma%3A%2025%20years%20of%20research%20and%20collaboration%20within%20the%20framework%20of%20the%20European%20Intergroup%20for%20Childhood%20Non-Hodgkin%20Lymphoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Auke%22%2C%22lastName%22%3A%22Beishuizen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karin%22%2C%22lastName%22%3A%22Mellgren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mara%22%2C%22lastName%22%3A%22Andr%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Auperin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%20M.%22%2C%22lastName%22%3A%22Bacon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Bomken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20A.%20Amos%22%2C%22lastName%22%3A%22Burke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Birgit%22%2C%22lastName%22%3A%22Burkhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Brugieres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%20K.%20S.%22%2C%22lastName%22%3A%22Chiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Damm-Welk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22d%27Amore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keizo%22%2C%22lastName%22%3A%22Horibe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edita%22%2C%22lastName%22%3A%22Kabickova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tasneem%22%2C%22lastName%22%3A%22Khanam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Udo%22%2C%22lastName%22%3A%22Kontny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wolfram%22%2C%22lastName%22%3A%22Klapper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Cecile%22%2C%22lastName%22%3A%22Le%20Deley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Loeffen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Macintyre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Mann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friederike%22%2C%22lastName%22%3A%22Meyer-Wentrup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulf%22%2C%22lastName%22%3A%22Michgehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronique%22%2C%22lastName%22%3A%22Minard-Colin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lara%22%2C%22lastName%22%3A%22Mussolin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilske%22%2C%22lastName%22%3A%22Oschlies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Patte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Pillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfred%22%2C%22lastName%22%3A%22Reiter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Rigaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leila%22%2C%22lastName%22%3A%22Roncery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itziar%22%2C%22lastName%22%3A%22Salaverria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingrid%22%2C%22lastName%22%3A%22Simonitsch-Klupp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Uyttebroeck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%22%2C%22lastName%22%3A%22Verdu-Amoros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilhelm%22%2C%22lastName%22%3A%22Woessmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Wotherspoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grazyna%22%2C%22lastName%22%3A%22Wrobel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Zimmermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andishe%22%2C%22lastName%22%3A%22Attarbaschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%20D.%22%2C%22lastName%22%3A%22Turner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22European%20Intergroup%20for%20Childhood%20Non-Hodgkin%20Lymphoma%22%7D%5D%2C%22abstractNote%22%3A%22The%20European%20Intergroup%20for%20Childhood%20Non-Hodgkin%20Lymphoma%20%28EICNHL%29%20was%20established%2025%20years%20ago%20with%20the%20goal%20to%20facilitate%20clinical%20trials%20and%20research%20collaborations%20in%20the%20field%20both%20within%20Europe%20and%20worldwide.%20Since%20its%20inception%2C%20much%20progress%20has%20been%20made%20whereby%20major%20improvements%20in%20outcomes%20have%20been%20achieved.%20In%20this%20Review%2C%20we%20describe%20the%20different%20diagnostic%20entities%20of%20non-Hodgkin%20lymphoma%20in%20children%20and%20young%20adults%20describing%20key%20features%20of%20each%20entity%20and%20outlining%20clinical%20achievements%20made%20in%20the%20context%20of%20the%20EICNHL%20framework.%20Furthermore%2C%20we%20provide%20an%20overview%20of%20advances%20in%20biopathology%20with%20an%20emphasis%20on%20the%20role%20of%20biological%20studies%20and%20how%20they%20have%20shaped%20available%20treatments.%20Finally%2C%20for%20each%20entity%2C%20we%20describe%20future%20goals%2C%20upcoming%20clinical%20trials%2C%20and%20highlight%20areas%20of%20research%20that%20require%20our%20focus%20going%20forward.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3026%2822%2900374-X%22%2C%22ISSN%22%3A%222352-3026%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-08-25T09%3A33%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22IXYXC3FX%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Troadec%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETroadec%2C%20Marie-B%26%23xE9%3Breng%26%23xE8%3Bre%2C%20Fran%26%23xE7%3Boise%20Porteu%2C%20Marie-Laure%20Arcangeli%2C%20Adlen%20Foudi%2C%20Dominique%20Bluteau%2C%20Paulo%20De%20Sepulveda%2C%20Christel%20Guillouf%2C%20et%20al.%20%26%23x201C%3BFrom%20Normal%20Hematopoiesis%20to%20Malignancies%3A%20Highlights%20from%20the%202021%20Meeting%20of%20the%20Club%20Hematopoiesis%20and%20Oncogenesis.%26%23x201D%3B%20%3Ci%3EBulletin%20Du%20Cancer%3C%5C%2Fi%3E%20110%2C%20no.%203%20%28March%202023%29%3A%20331%26%23x2013%3B35.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bulcan.2022.12.013%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bulcan.2022.12.013%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20normal%20hematopoiesis%20to%20malignancies%3A%20Highlights%20from%20the%202021%20Meeting%20of%20the%20Club%20Hematopoiesis%20and%20Oncogenesis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-B%5Cu00e9reng%5Cu00e8re%22%2C%22lastName%22%3A%22Troadec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Porteu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Arcangeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adlen%22%2C%22lastName%22%3A%22Foudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Bluteau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulo%22%2C%22lastName%22%3A%22De%20Sepulveda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christel%22%2C%22lastName%22%3A%22Guillouf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20M.%22%2C%22lastName%22%3A%22Mazure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Brunet%20De%20La%20Grange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyril%22%2C%22lastName%22%3A%22Broccardo%22%7D%5D%2C%22abstractNote%22%3A%22This%20article%20highlights%20the%20presentations%20from%20the%202021%20scientific%20meeting%20of%20the%20Club%20Hematopoiesis%20and%20Oncogenesis.%20This%20annual%20meeting%20focuses%20on%20hematopoiesis%20and%20oncogenic%20mechanisms.%20Various%20topics%20were%20presented%3A%20expansion%20of%20hematopoietic%20stem%20cells%20with%20in%20vivo%20and%20ex%20vivo%20strategies%2C%20the%20role%20of%20the%20hematopoietic%20stem%20cell%20niches%20in%20aging%20and%20leukemic%20resistance%2C%20the%20crossroad%20between%20hematology%20and%20immunology%2C%20the%20importance%20of%20the%20metabolism%20in%20normal%20hematopoiesis%20and%20hematopoietic%20defects%2C%20solid%20tumors%20and%20oncogenesis%2C%20the%20noncoding%20genome%2C%20inflammation%20in%20monocyte%20differentiation%20and%20leukemia%2C%20and%20importantly%2C%20the%20recent%20advances%20in%20myeloid%20malignancies%2C%20lymphoid%20leukemia%20and%20lymphoma.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bulcan.2022.12.013%22%2C%22ISSN%22%3A%221769-6917%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-08-25T09%3A33%3A25Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Cortacero, Kévin, Brienne McKenzie, Sabina Müller, Roxana Khazen, Fanny Lafouresse, Gaëlle Corsaut, Nathalie Van Acker, et al. “Evolutionary Design of Explainable Algorithms for Biomedical Image Segmentation.” Nature Communications<\/i> 14, no. 1 (November 6, 2023): 7112. https:\/\/doi.org\/10.1038\/s41467-023-42664-x<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Brugières, Laurence, Nathalie Cozic, Roch Houot, Charlotte Rigaud, David Sibon, Julia Arfi-Rouche, Pierre Bories, et al. “Efficacy and Safety of Crizotinib in ALK-Positive Systemic Anaplastic Large-Cell Lymphoma in Children, Adolescents, and Adult Patients: Results of the French AcSé-Crizotinib Trial.” European Journal of Cancer (Oxford, England: 1990)<\/i> 191 (July 17, 2023): 112984. https:\/\/doi.org\/10.1016\/j.ejca.2023.112984<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Legrand, Mélanie, Daniel Pissaloux, Franck Tirode, Anne Tallet, Christine Collin, Paul-Louis Chantreau, Patricia Berthon, et al. “SSTR2A Is a Diagnostic Marker of Trichogerminoma.” Journal of the European Academy of Dermatology and Venereology: JEADV<\/i>, July 8, 2023. https:\/\/doi.org\/10.1111\/jdv.19319<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Fuchs, Steffen, Clara Danßmann, Filippos Klironomos, Annika Winkler, Jörg Fallmann, Louisa-Marie Kruetzfeldt, Annabell Szymansky, et al. “Defining the Landscape of Circular RNAs in Neuroblastoma Unveils a Global Suppressive Function of MYCN.” Nature Communications<\/i> 14, no. 1 (July 4, 2023): 3936. https:\/\/doi.org\/10.1038\/s41467-023-38747-4<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Scholaert, Manon, Raissa Houmadi, Jeremy Martin, Nadine Serhan, Marie Tauber, Emilie Braun, Lilian Basso, et al. “3D Deconvolution of Human Skin Immune Architecture with Multiplex Annotated Tissue Imaging System.” Science Advances<\/i> 9, no. 23 (June 9, 2023): eadf9491. https:\/\/doi.org\/10.1126\/sciadv.adf9491<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Beishuizen, Auke, Karin Mellgren, Mara Andrés, Anne Auperin, Chris M. Bacon, Simon Bomken, G. A. Amos Burke, et al. “Improving Outcomes of Childhood and Young Adult Non-Hodgkin Lymphoma: 25 Years of Research and Collaboration within the Framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma.” The Lancet. Haematology<\/i> 10, no. 3 (March 2023): e213–24. https:\/\/doi.org\/10.1016\/S2352-3026(22)00374-X<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Troadec, Marie-Bérengère, Françoise Porteu, Marie-Laure Arcangeli, Adlen Foudi, Dominique Bluteau, Paulo De Sepulveda, Christel Guillouf, et al. “From Normal Hematopoiesis to Malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis.” Bulletin Du Cancer<\/i> 110, no. 3 (March 2023): 331–35. https:\/\/doi.org\/10.1016\/j.bulcan.2022.12.013<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2022″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.19.0″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2022<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-135fb8613fdf93601fc9a86c41c62ea1%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VPWC6YX7%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shin%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EShin%2C%20Sauyeun%2C%20Jacobo%20Solorzano%2C%20Mehdi%20Liauzun%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Corinne%20Bousquet%2C%20and%20Yvan%20Martineau.%20%26%23x201C%3BTranslational%20Alterations%20in%20Pancreatic%20Cancer%3A%20A%20Central%20Role%20for%20the%20Integrated%20Stress%20Response.%26%23x201D%3B%20%3Ci%3ENAR%20Cancer%3C%5C%2Fi%3E%204%2C%20no.%204%20%28December%202022%29%3A%20zcac031.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fnarcan%5C%2Fzcac031%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fnarcan%5C%2Fzcac031%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Translational%20alterations%20in%20pancreatic%20cancer%3A%20a%20central%20role%20for%20the%20integrated%20stress%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sauyeun%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacobo%22%2C%22lastName%22%3A%22Solorzano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Liauzun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%5D%2C%22abstractNote%22%3A%22mRNA%20translation%20is%20a%20key%20mechanism%20for%20cancer%20cell%20proliferation%20and%20stress%20adaptation.%20Regulation%20of%20this%20machinery%20implicates%20upstream%20pathways%20such%20as%20PI3K%5C%2FAKT%5C%2FmTOR%2C%20RAS%5C%2FMEK%5C%2FERK%20and%20the%20integrated%20stress%20response%20%28ISR%29%2C%20principally%20coordinating%20the%20translation%20initiation%20step.%20During%20the%20last%20decade%2C%20dysregulation%20of%20the%20mRNA%20translation%20process%20in%20pancreatic%20cancer%20has%20been%20widely%20reported%2C%20and%20shown%20to%20critically%20impact%20on%20cancer%20initiation%2C%20development%20and%20survival.%20This%20includes%20translation%20dysregulation%20of%20mRNAs%20encoding%20oncogenes%20and%20tumor%20suppressors.%20Hence%2C%20cancer%20cells%20survive%20a%20stressful%20microenvironment%20through%20a%20flexible%20regulation%20of%20translation%20initiation%20for%20rapid%20adaptation.%20The%20ISR%20pathway%20has%20an%20important%20role%20in%20chemoresistance%20and%20shows%20high%20potential%20therapeutic%20interest.%20Despite%20the%20numerous%20translational%20alterations%20reported%20in%20pancreatic%20cancer%2C%20their%20consequences%20are%20greatly%20underestimated.%20In%20this%20review%2C%20we%20summarize%20the%20different%20translation%20dysregulations%20described%20in%20pancreatic%20cancer%2C%20which%20make%20it%20invulnerable%2C%20as%20well%20as%20the%20latest%20drug%20discoveries%20bringing%20a%20glimmer%20of%20hope.%22%2C%22date%22%3A%222022-12%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fnarcan%5C%2Fzcac031%22%2C%22ISSN%22%3A%222632-8674%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222022-11-04T14%3A14%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22A8A76IKF%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carrier%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-28%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECarrier%2C%20Arnaud%2C%20C%26%23xE9%3Bcile%20Desjobert%2C%20Val%26%23xE9%3Brie%20Lobjois%2C%20Lise%20Rigal%2C%20Florence%20Busato%2C%20J%26%23xF6%3Brg%20Tost%2C%20Miquel%20Ensenyat-Mendez%2C%20et%20al.%20%26%23x201C%3BEpigenetically%20Regulated%20PCDHB15%20Impairs%20Aggressiveness%20of%20Metastatic%20Melanoma%20Cells.%26%23x201D%3B%20%3Ci%3EClinical%20Epigenetics%3C%5C%2Fi%3E%2014%2C%20no.%201%20%28November%2028%2C%202022%29%3A%20156.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13148-022-01364-x%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13148-022-01364-x%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epigenetically%20regulated%20PCDHB15%20impairs%20aggressiveness%20of%20metastatic%20melanoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Carrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Desjobert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Lobjois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lise%22%2C%22lastName%22%3A%22Rigal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Busato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00f6rg%22%2C%22lastName%22%3A%22Tost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miquel%22%2C%22lastName%22%3A%22Ensenyat-Mendez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diego%20M.%22%2C%22lastName%22%3A%22Marzese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Pradines%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Favre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22Lanfrancone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Etievant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%20B.%22%2C%22lastName%22%3A%22Arimondo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00eblle%22%2C%22lastName%22%3A%22Riond%22%7D%5D%2C%22abstractNote%22%3A%22The%20protocadherin%20proteins%20are%20cell%20adhesion%20molecules%20at%20the%20crossroad%20of%20signaling%20pathways%20playing%20a%20major%20role%20in%20neuronal%20development.%20It%20is%20now%20understood%20that%20their%20role%20as%20signaling%20hubs%20is%20not%20only%20important%20for%20the%20normal%20physiology%20of%20cells%20but%20also%20for%20the%20regulation%20of%20hallmarks%20of%20cancerogenesis.%20Importantly%2C%20protocadherins%20form%20a%20cluster%20of%20genes%20that%20are%20regulated%20by%20DNA%20methylation.%20We%20have%20identified%20for%20the%20first%20time%20that%20PCDHB15%20gene%20is%20DNA-hypermethylated%20on%20its%20unique%20exon%20in%20the%20metastatic%20melanoma-derived%20cell%20lines%20and%20patients%27%20metastases%20compared%20to%20primary%20tumors.%20This%20DNA%20hypermethylation%20silences%20the%20gene%2C%20and%20treatment%20with%20the%20DNA%20demethylating%20agent%205-aza-2%27-deoxycytidine%20reinduces%20its%20expression.%20We%20explored%20the%20role%20of%20PCDHB15%20in%20melanoma%20aggressiveness%20and%20showed%20that%20overexpression%20impairs%20invasiveness%20and%20aggregation%20of%20metastatic%20melanoma%20cells%20in%20vitro%20and%20formation%20of%20lung%20metastasis%20in%20vivo.%20These%20findings%20highlight%20important%20modifications%20of%20the%20methylation%20of%20the%20PCDH%5Cu03b2%20genes%20in%20melanoma%20and%20support%20a%20functional%20role%20of%20PCDHB15%20silencing%20in%20melanoma%20aggressiveness.%22%2C%22date%22%3A%222022-11-28%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13148-022-01364-x%22%2C%22ISSN%22%3A%221868-7083%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22W973EZ5X%22%2C%22VDZ48X5N%22%2C%22KC3WFBJR%22%5D%2C%22dateModified%22%3A%222024-02-13T10%3A17%3A06Z%22%7D%7D%2C%7B%22key%22%3A%229A6M78D5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carrier%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECarrier%2C%20Arnaud%2C%20C%26%23xE9%3Bcile%20Desjobert%2C%20Loic%20Ponger%2C%20Laurence%20Lamant%2C%20Matias%20Bustos%2C%20Jorge%20Torres-Ferreira%2C%20Rui%20Henrique%2C%20et%20al.%20%26%23x201C%3BDNA%20Methylome%20Combined%20with%20Chromosome%20Cluster-Oriented%20Analysis%20Provides%20an%20Early%20Signature%20for%20Cutaneous%20Melanoma%20Aggressiveness.%26%23x201D%3B%20%3Ci%3EELife%3C%5C%2Fi%3E%2011%20%28September%2020%2C%202022%29%3A%20e78587.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.78587%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7554%5C%2FeLife.78587%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22DNA%20methylome%20combined%20with%20chromosome%20cluster-oriented%20analysis%20provides%20an%20early%20signature%20for%20cutaneous%20melanoma%20aggressiveness%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Carrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Desjobert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Ponger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matias%22%2C%22lastName%22%3A%22Bustos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Torres-Ferreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rui%22%2C%22lastName%22%3A%22Henrique%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Jeronimo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luisa%22%2C%22lastName%22%3A%22Lanfrancone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Delmas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Favre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Daunay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Busato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dave%20S.%20B.%22%2C%22lastName%22%3A%22Hoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorg%22%2C%22lastName%22%3A%22Tost%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Etievant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jo%5Cu00eblle%22%2C%22lastName%22%3A%22Riond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%20B.%22%2C%22lastName%22%3A%22Arimondo%22%7D%5D%2C%22abstractNote%22%3A%22Aberrant%20DNA%20methylation%20is%20a%20well-known%20feature%20of%20tumours%20and%20has%20been%20associated%20with%20metastatic%20melanoma.%20However%2C%20since%20melanoma%20cells%20are%20highly%20heterogeneous%2C%20it%20has%20been%20challenging%20to%20use%20affected%20genes%20to%20predict%20tumour%20aggressiveness%2C%20metastatic%20evolution%2C%20and%20patients%27%20outcomes.%20We%20hypothesized%20that%20common%20aggressive%20hypermethylation%20signatures%20should%20emerge%20early%20in%20tumorigenesis%20and%20should%20be%20shared%20in%20aggressive%20cells%2C%20independent%20of%20the%20physiological%20context%20under%20which%20this%20trait%20arises.%20We%20compared%20paired%20melanoma%20cell%20lines%20with%20the%20following%20properties%3A%20%28i%29%20each%20pair%20comprises%20one%20aggressive%20counterpart%20and%20its%20parental%20cell%20line%20and%20%28ii%29%20the%20aggressive%20cell%20lines%20were%20each%20obtained%20from%20different%20host%20and%20their%20environment%20%28human%2C%20rat%2C%20and%20mouse%29%2C%20though%20starting%20from%20the%20same%20parent%20cell%20line.%20Next%2C%20we%20developed%20a%20multi-step%20genomic%20pipeline%20that%20combines%20the%20DNA%20methylome%20profile%20with%20a%20chromosome%20cluster-oriented%20analysis.%20A%20total%20of%20229%20differentially%20hypermethylated%20genes%20was%20commonly%20found%20in%20the%20aggressive%20cell%20lines.%20Genome%20localization%20analysis%20revealed%20hypermethylation%20peaks%20and%20clusters%2C%20identifying%20eight%20hypermethylated%20gene%20promoters%20for%20validation%20in%20tissues%20from%20melanoma%20patients.%20Five%20Cytosine-phosphate-Guanine%20%28CpGs%29%20identified%20in%20primary%20melanoma%20tissues%20were%20transformed%20into%20a%20DNA%20methylation%20score%20that%20can%20predict%20survival%20%28log-rank%20test%2C%20p%3D0.0008%29.%20This%20strategy%20is%20potentially%20universally%20applicable%20to%20other%20diseases%20involving%20DNA%20methylation%20alterations.%22%2C%22date%22%3A%222022-09-20%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.78587%22%2C%22ISSN%22%3A%222050-084X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22W973EZ5X%22%2C%22VDZ48X5N%22%2C%22KC3WFBJR%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A19%3A22Z%22%7D%7D%2C%7B%22key%22%3A%229SIW6LCS%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fuchs%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuchs%2C%20Steffen%2C%20Lo%26%23xE9%3Blia%20Babin%2C%20Elissa%20Andraos%2C%20Chlo%26%23xE9%3B%20Bessiere%2C%20Semjon%20Willier%2C%20Johannes%20H.%20Schulte%2C%20Christine%20Gaspin%2C%20and%20Fabienne%20Meggetto.%20%26%23x201C%3BGeneration%20of%20Full-Length%20Circular%20RNA%20Libraries%20for%20Oxford%20Nanopore%20Long-Read%20Sequencing.%26%23x201D%3B%20%3Ci%3EPloS%20One%3C%5C%2Fi%3E%2017%2C%20no.%209%20%28September%207%2C%202022%29%3A%20e0273253.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0273253%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0273253%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Generation%20of%20full-length%20circular%20RNA%20libraries%20for%20Oxford%20Nanopore%20long-read%20sequencing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steffen%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lo%5Cu00e9lia%22%2C%22lastName%22%3A%22Babin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elissa%22%2C%22lastName%22%3A%22Andraos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chlo%5Cu00e9%22%2C%22lastName%22%3A%22Bessiere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Semjon%22%2C%22lastName%22%3A%22Willier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%20H.%22%2C%22lastName%22%3A%22Schulte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Gaspin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22Circular%20RNA%20%28circRNA%29%20is%20a%20noncoding%20RNA%20class%20with%20important%20implications%20for%20gene%20expression%20regulation%2C%20mostly%20by%20interaction%20with%20other%20RNA%20species%20or%20RNA-binding%20proteins.%20While%20the%20commonly%20applied%20short-read%20Illumina%20RNA-sequencing%20techniques%20can%20be%20used%20to%20detect%20circRNAs%2C%20their%20full%20sequence%20is%20not%20revealed.%20However%2C%20the%20complete%20sequence%20information%20is%20needed%20to%20analyze%20potential%20interactions%20and%20thus%20the%20mechanism%20of%20action%20of%20circRNAs.%20Here%2C%20we%20present%20an%20improved%20protocol%20to%20enrich%20and%20sequence%20full-length%20circRNAs%20by%20using%20the%20Oxford%20Nanopore%20long-read%20sequencing%20platform.%20The%20protocol%20involves%20an%20enrichment%20of%20lowly%20abundant%20circRNAs%20by%20exonuclease%20treatment%20and%20negative%20selection%20of%20linear%20RNAs.%20Then%2C%20a%20cDNA%20library%20is%20created%20and%20amplified%20by%20PCR.%20This%20protocol%20provides%20enough%20material%20for%20several%20sequencing%20runs.%20The%20library%20is%20used%20as%20input%20for%20ligation-based%20sequencing%20together%20with%20native%20barcoding.%20Stringent%20quality%20control%20of%20the%20libraries%20is%20ensured%20by%20a%20combination%20of%20Qubit%2C%20Fragment%20Analyzer%20and%20qRT-PCR.%20Multiplexing%20of%20up%20to%204%20libraries%20yields%20in%20total%20more%20than%201-2%20Million%20reads%20per%20library%2C%20of%20which%201-2%25%20are%20circRNA-specific%20reads%20with%20%3E99%25%20of%20them%20full-length.%20The%20protocol%20works%20well%20with%20human%20cancer%20cell%20lines.%20We%20further%20provide%20suggestions%20for%20the%20bioinformatic%20analysis%20of%20the%20created%20data%2C%20as%20well%20as%20the%20limitations%20of%20our%20approach%20together%20with%20recommendations%20for%20troubleshooting%20and%20interpretation.%20Taken%20together%2C%20this%20protocol%20enables%20reliable%20full-length%20analysis%20of%20circRNAs%2C%20a%20noncoding%20RNA%20type%20involved%20in%20a%20growing%20number%20of%20physiologic%20and%20pathologic%20conditions.%20Metadata%20Associated%20content.%20https%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.17504%5C%2Fprotocols.io.rm7vzy8r4lx1%5C%2Fv2.%22%2C%22date%22%3A%222022-09-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0273253%22%2C%22ISSN%22%3A%221932-6203%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-03T10%3A11%3A56Z%22%7D%7D%2C%7B%22key%22%3A%224ZD58ENA%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Soulages%20et%20al.%22%2C%22parsedDate%22%3A%222022-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESoulages%2C%20Antoine%2C%20Thierry%20Maisonobe%2C%20Pascal%20Auzou%2C%20Antoine%20Petit%2C%20Yves%20Allenbach%2C%20St%26%23xE9%3Bphane%20Bar%26%23xE8%3Bte%2C%20Sophie%20Skopinski%2C%20et%20al.%20%26%23x201C%3BPeripheral%20Neuropathy%20and%20Livedoid%20Vasculopathy.%26%23x201D%3B%20%3Ci%3EJournal%20of%20Neurology%3C%5C%2Fi%3E%20269%2C%20no.%207%20%28July%202022%29%3A%203779%26%23x2013%3B88.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00415-022-11007-z%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00415-022-11007-z%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peripheral%20neuropathy%20and%20livedoid%20vasculopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Soulages%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Maisonobe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Auzou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Petit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Allenbach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Bar%5Cu00e8te%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Skopinski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Julli%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Brevet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Soulages%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Michel%22%2C%22lastName%22%3A%22Vallat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Martin-N%5Cu00e9grier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilhem%22%2C%22lastName%22%3A%22Sol%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Duval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%22%2C%22lastName%22%3A%22Carla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwendal%22%2C%22lastName%22%3A%22Le%20Masson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Mathis%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Livedoid%20vasculopathy%20%28LV%29%20is%20a%20chronic%20dermatosis%20associated%20with%20micro-thrombosis%20of%20the%20vessels%20of%20the%20dermis%2C%20leading%20to%20ischemic%20lesions%20and%20painful%20skin%20ulcerations%20of%20the%20lower%20limbs.%20This%20thrombosing%20occlusive%20vasculopathy%2C%20clearly%20distinct%20from%20%27classical%20vasculitis%27%20%28not%20related%20to%20alteration%20of%20vessel%20walls%29%2C%20may%20lead%20to%20peripheral%20neuropathy.%5CnOBJECTIVE%3A%20To%20clarify%20the%20main%20clinical%2C%20electrophysiological%20and%20pathological%20characteristics%20of%20peripheral%20neuropathy%20linked%20to%20LV.%5CnMETHOD%3A%20We%20presented%20a%20series%20of%20personal%20cases%20of%20peripheral%20neuropathy%20due%20to%20LV.%20We%20also%20conducted%20a%20review%20of%20the%20literature%20%28since%20the%20first%20description%20of%20LV%20in%201974%29%20using%20multiple%20combinations%20of%20keywords%20from%20%27PubMed%27%2C%20%27Google%20Scholar%27%20and%20%27ScienceDirect%27%20databases%20according%20to%20the%20%27Preferred%20Reporting%20Items%20for%20Systematic%20reviews%20and%20Meta-Analyses%27%20guidelines.%5CnRESULTS%3A%20We%20identified%2016%20patients%20%286%20personal%20cases%20and%2010%20cases%20from%20the%20medical%20literature%29.%20Our%20personal%20cases%20were%20five%20females%20and%20one%20male%2C%20with%20a%20median%20age%20%28at%20the%20onset%20of%20cutaneous%20signs%20of%20LV%29%20of%2038%20%28range%2025-62%29.%20Several%20types%20of%20skin%20lesions%20of%20the%20lower%20limbs%20were%20observed.%20Median%20age%20at%20the%20onset%20of%20peripheral%20neuropathy%20symptoms%20was%2048%5Cu00a0years%20%28range%2029-66%29%2C%20with%20a%20main%20clinical%20and%20electrophysiological%20pattern%20of%20mononeuropathy%20multiplex.%5CnDISCUSSION%3A%20We%20observed%20a%20typical%20pattern%20of%20peripheral%20neuropathy%2C%20mostly%20mononeuropathy%20multiplex%2C%20whose%20pathophysiology%20might%20be%20related%20to%20occlusions%20of%20the%20small%20vessels%20of%20the%20nerves%2C%20as%20seen%20in%20the%20dermis.%20Moreover%2C%20LV%20may%20also%20be%20associated%20with%20other%20types%20of%20peripheral%20neuropathies%20%28sometimes%20of%20autoimmune%20etiology%29%20not%20directly%20related%20to%20the%20skin%20lesions.%5CnCONCLUSION%3A%20The%20%27ischemic%20form%27%20of%20peripheral%20neuropathy%20linked%20to%20LV%20is%20mainly%20responsible%20for%20sensory%20disturbances%20%28with%20multifocal%20distribution%29%2C%20sometimes%20for%20motor%20disturbances.%20This%20type%20of%20peripheral%20neuropathy%20has%20to%20be%20distinguished%20from%20%27classical%20vasculitic%20neuropathies%27%20which%20are%20usually%20treated%20with%20antithrombotic%20therapies.%22%2C%22date%22%3A%222022-07%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00415-022-11007-z%22%2C%22ISSN%22%3A%221432-1459%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A18%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22AGHU4S85%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Darmon-Novello%20et%20al.%22%2C%22parsedDate%22%3A%222022-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDarmon-Novello%2C%20Marie%2C%20Julien%20Adam%2C%20Laurence%20Lamant%2C%20Maxime%20Battistella%2C%20Nicolas%20Ortonne%2C%20Brigitte%20Balme%2C%20A.%20de%20la%20Fouchardi%26%23xE8%3Bre%2C%20et%20al.%20%26%23x201C%3BHarmonization%20of%20Programmed%20Death-Ligand%201%20Immunohistochemistry%20and%20MRNA%20Expression%20Scoring%20in%20Metastatic%20Melanoma%3A%20A%20Multicentre%20Analysis.%26%23x201D%3B%20%3Ci%3EHistopathology%3C%5C%2Fi%3E%2080%2C%20no.%207%20%28June%202022%29%3A%201091%26%23x2013%3B1101.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fhis.14651%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fhis.14651%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Harmonization%20of%20programmed%20death-ligand%201%20immunohistochemistry%20and%20mRNA%20expression%20scoring%20in%20metastatic%20melanoma%3A%20a%20multicentre%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Darmon-Novello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Adam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Battistella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Ortonne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Balme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22de%20la%20Fouchardi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonor%22%2C%22lastName%22%3A%22Chaltiel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Gerard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Franchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Vergier%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20The%20aim%20of%20this%20multicentre%20study%20was%20to%20harmonize%20programmed%20death-ligand%201%20%28PD-L1%29%20immunohistochemistry%20%28IHC%29%20and%20melanoma%20scoring.%20To%20provide%20a%20reference%20for%20PD-L1%20expression%20independently%20of%20the%20IHC%20protocol%2C%20PD-L1%20mRNA%20expression%20was%20compared%20with%20IHC.%5CnMETHODS%20AND%20RESULTS%3A%20Standardized%20PD-L1%20assays%20%2822C3%2C%2028-8%2C%20SP142%2C%20SP263%29%20and%20laboratory-developed%20tests%20%28QR1%2C%2022C3%29%20were%20evaluated%20on%20three%20IHC%20platforms%20with%20a%20training%20set%20%28seven%20cases%29.%20mRNA%20expression%20was%20determined%20by%20RNAscope%20%28CD274%5C%2FPD-L1%20probe%29%20and%20analysed%20with%20image%20analysis.%20PD-L1%20IHC%20findings%20were%20scored%20by%20seven%20blinded%20pathologists%20using%20the%20tumour%20proportion%20score%20%28TPS%29%2C%20the%20combined%20positive%20score%20%28CPS%29%2C%20and%20the%20MELscore.%20This%20method%20was%20validated%20by%20three%20blinded%20pathologists%20on%2040%20metastatic%20melanomas.%20Concordances%20among%20various%20antibody%5C%2Fplatforms%20were%20high%20across%20antibodies%20%5Bintraclass%20correlation%20coefficient%20%28ICC%29%20%3E0.80%20for%20the%20CPS%5D%2C%20except%20for%20SP142.%20Two%20levels%20of%20immunostaining%20intensity%20were%20observed%3A%20high%20%28QR1%20and%20SP263%29%20and%20low%20%2828-8%2C%2022C3%2C%20and%20SP142%29.%20Reproducibilities%20across%20pathologists%20were%20higher%20for%20QR1%20and%20SP263%20%28ICC%20%5Cu22650.87%20and%20ICC%20%5Cu22650.85%20for%20the%20TPS%20and%20the%20CPS%2C%20respectively%29.%20QR1%2C%20SP263%20and%2028-8%20showed%20the%20highest%20concordance%20with%20mRNA%20expression.%20We%20developed%20a%20standardized%20method%20for%20PD-L1%20immunodetection%20and%20scoring%2C%20tested%20on%2040%20metastatic%20melanomas.%20Concordances%20among%20antibodies%20were%20excellent%20for%20all%20criteria%2C%20and%20concordances%20among%20pathologists%20were%20better%20for%20the%20MELscore%20than%20for%20other%20scores.%5CnCONCLUSION%3A%20Harmonization%20of%20PD-L1%20staining%20and%20scoring%20in%20melanomas%20with%20good%20concordance%20is%20achievable%20with%20the%20PD-L1%20IHC%20protocols%20applied%20to%20other%20cancers%3B%20this%20reproducible%20approach%20can%20simplify%20daily%20practice.%22%2C%22date%22%3A%222022-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fhis.14651%22%2C%22ISSN%22%3A%221365-2559%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A17%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22TNVJ4WU5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kervarrec%20et%20al.%22%2C%22parsedDate%22%3A%222022-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKervarrec%2C%20Thibault%2C%20Daniel%20Pissaloux%2C%20Jeremie%20Poilane%2C%20Franck%20Tirode%2C%20Anne%20Tallet%2C%20Christine%20Collin%2C%20Matthias%20Tallegas%2C%20et%20al.%20%26%23x201C%3BRecurrent%20FOXK1%3A%3AGRHL%20and%20GPS2%3A%3AGRHL%20Fusions%20in%20Trichogerminoma.%26%23x201D%3B%20%3Ci%3EThe%20Journal%20of%20Pathology%3C%5C%2Fi%3E%20257%2C%20no.%201%20%28May%202022%29%3A%2096%26%23x2013%3B108.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fpath.5872%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fpath.5872%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Recurrent%20FOXK1%3A%3AGRHL%20and%20GPS2%3A%3AGRHL%20fusions%20in%20trichogerminoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibault%22%2C%22lastName%22%3A%22Kervarrec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Pissaloux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremie%22%2C%22lastName%22%3A%22Poilane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franck%22%2C%22lastName%22%3A%22Tirode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Tallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Collin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Tallegas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Berthon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauline%22%2C%22lastName%22%3A%22Gaboriaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Sohier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Calonje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%5Cu0161tjan%22%2C%22lastName%22%3A%22Luzar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keisuke%22%2C%22lastName%22%3A%22Goto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristof%22%2C%22lastName%22%3A%22Cokelaere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Balme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Wild%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agnes%22%2C%22lastName%22%3A%22Neuville%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lydia%22%2C%22lastName%22%3A%22Deschamps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Auberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronique%22%2C%22lastName%22%3A%22Paumier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helene%22%2C%22lastName%22%3A%22Bonte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Moulonguet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Plantier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Cales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Pinsolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Roblet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frantz%22%2C%22lastName%22%3A%22Dupuy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexiane%22%2C%22lastName%22%3A%22Dallot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Seris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Jouary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Houben%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schrama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonja%22%2C%22lastName%22%3A%22Hesbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Macagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Battistella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cribier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatrice%22%2C%22lastName%22%3A%22Vergier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22de%20la%20Fouchardi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Jullie%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%2021%20cases%20of%20trichogerminoma%20harbouring%20previously%20undescribed%20FOXK1%3A%3AGRHL1%5C%2F2%20or%20GPS2%3A%3AGRHL1%5C%2F2%5C%2F3%20in-frame%20fusion%20transcripts.%20Microscopic%20examination%20of%20a%20preliminary%20set%20of%20five%20cases%20revealed%20well-delimitated%20tumours%20located%20in%20the%20dermis%20with%20frequent%20extension%20to%20the%20subcutaneous%20tissue.%20Tumours%20presented%20a%20massive%20and%20nodular%20architecture%20and%20consisted%20of%20a%20proliferation%20of%20basaloid%20cells.%20A%20biphasic%20pattern%20sometime%20resulting%20in%20tumour%20cell%20nests%20%28%27cell%20balls%27%29%20was%20present.%20Immunohistochemistry%20demonstrated%20the%20expression%20of%20cytokeratins%20%28CKs%29%2015%2C%2017%2C%20and%20PHLDA1.%20In%20addition%2C%20numerous%20CK20-positive%20Merkel%20cells%20were%20detected.%20RNA%20sequencing%20%28RNA-seq%29%20revealed%20a%20FOXK1%3A%3AGRHL1%20chimeric%20transcript%20in%20three%20cases%20and%20a%20FOXK1%3A%3AGRHL2%20fusion%20in%20two%20cases.%20In%20a%20second%20series%20for%20validation%20%28n%5Cu2009%3D%5Cu200988%29%2C%20FOXK1%3A%3AGRHL1%5C%2F2%20fusion%20transcripts%20were%20detected%20by%20RT-qPCR%20or%20FISH%20in%20an%20additional%2012%20trichogerminomas%20and%20not%20in%20any%20other%20follicular%20tumour%20entities%20or%20basal%20cell%20carcinoma%20cases%20%28n%5Cu2009%3D%5Cu200966%29.%20Additional%20RNA-seq%20analysis%20in%20trichogerminoma%20cases%20without%20detected%20FOXK1%3A%3AGRHL1%5C%2F2%20rearrangements%20revealed%20GPS2%3A%3AGRHL1%20fusion%20transcripts%20in%20two%20cases%2C%20GPS2%3A%3AGRHL2%20in%20one%20case%2C%20and%20GPS2%3A%3AGRHL3%20fusion%20transcript%20in%20one%20case.%20Therefore%2C%20our%20study%20strongly%20suggests%20that%20GRHL1%5C%2F2%5C%2F3%20gene%20rearrangements%20might%20represent%20the%20oncogenic%20driver%20in%20trichogerminoma%2C%20a%20subset%20of%20follicular%20tumours%20characterized%20by%20immature%20features%20and%20numerous%20Merkel%20cells.%20%5Cu00a9%202022%20The%20Pathological%20Society%20of%20Great%20Britain%20and%20Ireland.%22%2C%22date%22%3A%222022-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fpath.5872%22%2C%22ISSN%22%3A%221096-9896%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A18%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22VN8IAP6B%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vergnolle%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-22%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVergnolle%2C%20In%26%23xE8%3Bs%2C%20Claudia%20Douat-Beyries%2C%20Serge%20Boulinguez%2C%20Jean-Baptiste%20Rieu%2C%20Jean-Philippe%20Vial%2C%20Rolande%20Baracou%2C%20Sylvie%20Boudot%2C%20et%20al.%20%26%23x201C%3BCD158k%20and%20PD-1%20Expressions%20Define%20Heterogeneous%20Subtypes%20of%20Sezary%20Syndrome.%26%23x201D%3B%20%3Ci%3EBlood%20Advances%3C%5C%2Fi%3E%206%2C%20no.%206%20%28March%2022%2C%202022%29%3A%201813%26%23x2013%3B25.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021005147%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021005147%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CD158k%20and%20PD-1%20expressions%20define%20heterogeneous%20subtypes%20of%20Sezary%20syndrome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22In%5Cu00e8s%22%2C%22lastName%22%3A%22Vergnolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Douat-Beyries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%22%2C%22lastName%22%3A%22Boulinguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Baptiste%22%2C%22lastName%22%3A%22Rieu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Philippe%22%2C%22lastName%22%3A%22Vial%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rolande%22%2C%22lastName%22%3A%22Baracou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Boudot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurore%22%2C%22lastName%22%3A%22Cazeneuve%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Chaugne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martine%22%2C%22lastName%22%3A%22Durand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Estival%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Lablanche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Nicolau-Travers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Tournier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Vergez%22%7D%5D%2C%22abstractNote%22%3A%22Sezary%20syndrome%20%28SS%29%20is%20a%20rare%20leukemic%20form%20of%20cutaneous%20T-cell%20lymphoma.%20Diagnosis%20mainly%20depends%20on%20flow%20cytometry%2C%20but%20results%20are%20not%20specific%20enough%20to%20be%20unequivocal.%20The%20difficulty%20in%20defining%20a%20single%20marker%20that%20could%20characterize%20Sezary%20cells%20may%20be%20the%20consequence%20of%20different%20pathological%20subtypes.%20In%20this%20study%2C%20we%20used%20multivariate%20flow%20cytometry%20analyses.%20We%20chose%20to%20investigate%20the%20expression%20of%20classical%20CD3%2C%20CD4%2C%20CD7%2C%20and%20CD26%20and%20the%20new%20association%20of%202%20markers%20CD158k%20and%20PD-1.%20We%20performed%20lymphocyte%20computational%20phenotypic%20analyses%20during%20diagnosis%20and%20follow-up%20of%20patients%20with%20SS%20to%20define%20new%20SS%20classes%20and%20improve%20the%20sensitivity%20of%20the%20diagnosis%20and%20the%20follow-up%20flow%20cytometry%20method.%20Three%20classes%20of%20SS%2C%20defined%20by%20different%20immunophenotypic%20profiles%2C%20CD158k%2B%20SS%2C%20CD158k-PD-1%2B%20SS%2C%20CD158k%20and%20PD-1%20double-negative%20SS%2C%20showed%20different%20CD8%2B%20and%20B-cell%20environments.%20Such%20a%20study%20could%20help%20to%20diagnose%20and%20define%20biological%20markers%20of%20susceptibility%5C%2Fresistance%20to%20treatment%2C%20including%20immunotherapy.%22%2C%22date%22%3A%222022-03-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1182%5C%2Fbloodadvances.2021005147%22%2C%22ISSN%22%3A%222473-9537%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A19%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22EGELJH3D%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Babin%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-04%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBabin%2C%20Lo%26%23xE9%3Blia%2C%20Alice%20Darchen%2C%20Elie%20Robert%2C%20Zakia%20Aid%2C%20Rosalie%20Borry%2C%20Claire%20Soudais%2C%20Marion%20Piganeau%2C%20et%20al.%20%26%23x201C%3BDe%20Novo%20Generation%20of%20the%20NPM-ALK%20Fusion%20Recapitulates%20the%20Pleiotropic%20Phenotypes%20of%20ALK%2B%20ALCL%20Pathogenesis%20and%20Reveals%20the%20ROR2%20Receptor%20as%20Target%20for%20Tumor%20Cells.%26%23x201D%3B%20%3Ci%3EMolecular%20Cancer%3C%5C%2Fi%3E%2021%2C%20no.%201%20%28March%204%2C%202022%29%3A%2065.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12943-022-01520-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12943-022-01520-0%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22De%20novo%20generation%20of%20the%20NPM-ALK%20fusion%20recapitulates%20the%20pleiotropic%20phenotypes%20of%20ALK%2B%20ALCL%20pathogenesis%20and%20reveals%20the%20ROR2%20receptor%20as%20target%20for%20tumor%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lo%5Cu00e9lia%22%2C%22lastName%22%3A%22Babin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Darchen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elie%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zakia%22%2C%22lastName%22%3A%22Aid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosalie%22%2C%22lastName%22%3A%22Borry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Soudais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Piganeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22De%20Cian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carine%22%2C%22lastName%22%3A%22Giovannangeli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivia%22%2C%22lastName%22%3A%22Bawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Rigaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Yves%22%2C%22lastName%22%3A%22Scoazec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucile%22%2C%22lastName%22%3A%22Couronn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Layla%22%2C%22lastName%22%3A%22Veleanu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agata%22%2C%22lastName%22%3A%22Cieslak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vahid%22%2C%22lastName%22%3A%22Asnafi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Sibon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Mercher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Brunet%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Anaplastic%20large%20cell%20lymphoma%20positive%20for%20ALK%20%28ALK%2B%20ALCL%29%20is%20a%20rare%20type%20of%20non-Hodgkin%20lymphoma.%20This%20lymphoma%20is%20caused%20by%20chromosomal%20translocations%20involving%20the%20anaplastic%20lymphoma%20kinase%20gene%20%28ALK%29.%20In%20this%20study%2C%20we%20aimed%20to%20identify%20mechanisms%20of%20transformation%20and%20therapeutic%20targets%20by%20generating%20a%20model%20of%20ALK%2B%20ALCL%20lymphomagenesis%20ab%20initio%20with%20the%20specific%20NPM-ALK%20fusion.%5CnMETHODS%3A%20We%20performed%20CRISPR%5C%2FCas9-mediated%20genome%20editing%20of%20the%20NPM-ALK%20chromosomal%20translocation%20in%20primary%20human%20activated%20T%20lymphocytes.%5CnRESULTS%3A%20Both%20CD4%2B%20and%20CD8%2B%20NPM-ALK-edited%20T%20lymphocytes%20showed%20rapid%20and%20reproducible%20competitive%20advantage%20in%20culture%20and%20led%20to%20in%20vivo%20disease%20development%20with%20nodal%20and%20extra-nodal%20features.%20Murine%20tumors%20displayed%20the%20phenotypic%20diversity%20observed%20in%20ALK%2B%20ALCL%20patients%2C%20including%20CD4%2B%20and%20CD8%2B%20lymphomas.%20Assessment%20of%20transcriptome%20data%20from%20models%20and%20patients%20revealed%20global%20activation%20of%20the%20WNT%20signaling%20pathway%2C%20including%20both%20canonical%20and%20non-canonical%20pathways%2C%20during%20ALK%2B%20ALCL%20lymphomagenesis.%20Specifically%2C%20we%20found%20that%20the%20WNT%20signaling%20cell%20surface%20receptor%20ROR2%20represented%20a%20robust%20and%20genuine%20marker%20of%20all%20ALK%2B%20ALCL%20patient%20tumor%20samples.%5CnCONCLUSIONS%3A%20In%20this%20study%2C%20ab%20initio%20modeling%20of%20the%20ALK%2B%20ALCL%20chromosomal%20translocation%20in%20mature%20T%20lymphocytes%20enabled%20the%20identification%20of%20new%20therapeutic%20targets.%20As%20ROR2%20targeting%20approaches%20for%20other%20cancers%20are%20under%20development%20%28including%20lung%20and%20ovarian%20tumors%29%2C%20our%20findings%20suggest%20that%20ALK%2B%20ALCL%20cases%20with%20resistance%20to%20current%20therapies%20may%20also%20benefit%20from%20ROR2%20targeting%20strategies.%22%2C%22date%22%3A%222022-03-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12943-022-01520-0%22%2C%22ISSN%22%3A%221476-4598%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A19%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22DI7UNSDS%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Battistella%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBattistella%2C%20Maxime%2C%20Brigitte%20Balme%2C%20Marie-Laure%20Jullie%2C%20Ute%20Zimmermann%2C%20Agn%26%23xE8%3Bs%20Carlotti%2C%20Marie%20Crinquette%2C%20Eric%20Frouin%2C%20et%20al.%20%26%23x201C%3BImpact%20of%20Expert%20Pathology%20Review%20in%20Skin%20Adnexal%20Carcinoma%20Diagnosis%3A%20Analysis%20of%202573%20Patients%20from%20the%20French%20CARADERM%20Network.%26%23x201D%3B%20%3Ci%3EEuropean%20Journal%20of%20Cancer%20%28Oxford%2C%20England%3A%201990%29%3C%5C%2Fi%3E%20163%20%28March%202022%29%3A%20211%26%23x2013%3B21.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejca.2021.11.027%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ejca.2021.11.027%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20expert%20pathology%20review%20in%20skin%20adnexal%20carcinoma%20diagnosis%3A%20Analysis%20of%202573%20patients%20from%20the%20French%20CARADERM%20network%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Battistella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Balme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Jullie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ute%22%2C%22lastName%22%3A%22Zimmermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Carlotti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Crinquette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Frouin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Macagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Ortonne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22de%20la%20Fouchardiere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Aubriot-Lorton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%22%2C%22lastName%22%3A%22Durand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Josselin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Franck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Chatelain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Lemasson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Paule%22%2C%22lastName%22%3A%22Algros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Durlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Christine%22%2C%22lastName%22%3A%22Machet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Courville%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Osio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Seris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Mortier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Jouary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cribier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22CARADERM%20network%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20To%20prospectively%20assess%20the%20impact%20of%20expert%20pathological%20review%20of%20skin%20adnexal%20carcinoma%20diagnosis%20in%20France.%5CnMETHODS%3A%20From%202014%20to%202019%2C%202573%20samples%20from%20patients%20with%20newly%20diagnosed%20or%20suspected%20skin%20adnexal%20carcinomas%20were%20reviewed%20prospectively%20by%20expert%20pathologists%20through%20the%20national%20CARADERM%20%28CAncers%20RAres%20DERMatologiques%29%20network.%20Changes%20in%20diagnosis%20between%20referral%20and%20expert%20review%20were%20analysed%20regarding%20their%20potential%20impact%20on%20patient%20care%20or%20prognosis.%5CnRESULTS%3A%20The%20samples%20comprised%202205%20newly%20diagnosed%20adnexal%20carcinomas%2C%20129%20benign%20adnexal%20tumours%2C%20136%20basal%20cell%20carcinomas%2C%2074%20squamous%20cell%20carcinomas%2C%20six%20cutaneous%20metastases%20and%2013%20other%20malignancies.%20There%20were%20930%20%2842%25%29%20sweat%20gland%20carcinomas%2C%20of%20which%20porocarcinoma%20%28261%3B%2011.8%25%29%2C%20microcystic%20adnexal%20carcinoma%20%28125%3B%205.7%25%29%20and%20hidradenocarcinoma%20%28109%3B%204.9%25%29%20were%20the%20most%20frequent%20subtypes%3B%20778%20%2835%25%29%20hair%20follicle%20carcinomas%2C%20238%20%2811%25%29%20sebaceous%20carcinomas%20and%20212%20%2810%25%29%20extramammary%20Paget%20diseases%5C%2Fmammary-like%20anogenital%20gland%20adenocarcinomas.%20A%20diagnostic%20change%20between%20referral%20and%20expert%20review%20occurred%20in%20503%20%2821.3%25%29%20patients%2C%20significantly%20higher%20for%20cases%20sent%20with%20a%20provisional%20diagnosis%20seeking%20an%20expert%20second%20opinion%20%2845.7%25%29%20than%20for%20cases%20sent%20with%20a%20formal%20diagnosis%20%282.8%25%29%20%28p%5Cu00a0%3C%5Cu00a0.0001%29.%20Sweat%20gland%20carcinomas%20were%20more%20prone%20to%20diagnostic%20discrepancies%20than%20other%20tumours%20%28p%5Cu00a0%3C%5Cu00a0.0001%29%2C%20including%201.8%25%20of%20patients%20with%20sweat%20gland%20carcinoma%20subtype%20misclassification%20with%20predicted%20clinical%20impact.%20Changes%20between%20benign%20and%20malignant%20conditions%20occurred%20in%20117%20samples%20%285%25%20of%20patients%29.%5CnCONCLUSION%3A%20The%20study%20provides%20a%20unique%20description%20of%20the%20distribution%20of%20skin%20adnexal%20carcinomas%20and%20highlights%20the%20importance%20of%20expert%20review%20for%20these%20rare%20cancers.%20Optimal%20clinical%20management%20was%20impacted%20in%20a%20significant%20proportion%20of%20patients.%22%2C%22date%22%3A%222022-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ejca.2021.11.027%22%2C%22ISSN%22%3A%221879-0852%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A18%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22X5EWNQNM%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Filali%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-18%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFilali%2C%20Liza%2C%20Marie-Pierre%20Puissegur%2C%20Kevin%20Cortacero%2C%20Sylvain%20Cussat-Blanc%2C%20Roxana%20Khazen%2C%20Nathalie%20Van%20Acker%2C%20Fran%26%23xE7%3Bois-Xavier%20Frenois%2C%20et%20al.%20%26%23x201C%3BUltrarapid%20Lytic%20Granule%20Release%20from%20CTLs%20Activates%20Ca2%2B-Dependent%20Synaptic%20Resistance%20Pathways%20in%20Melanoma%20Cells.%26%23x201D%3B%20%3Ci%3EScience%20Advances%3C%5C%2Fi%3E%208%2C%20no.%207%20%28February%2018%2C%202022%29%3A%20eabk3234.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.abk3234%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciadv.abk3234%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ultrarapid%20lytic%20granule%20release%20from%20CTLs%20activates%20Ca2%2B-dependent%20synaptic%20resistance%20pathways%20in%20melanoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liza%22%2C%22lastName%22%3A%22Filali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Pierre%22%2C%22lastName%22%3A%22Puissegur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Cortacero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Cussat-Blanc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxana%22%2C%22lastName%22%3A%22Khazen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Van%20Acker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois-Xavier%22%2C%22lastName%22%3A%22Frenois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Abreu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Meyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Vergier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brienne%22%2C%22lastName%22%3A%22McKenzie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Valitutti%22%7D%5D%2C%22abstractNote%22%3A%22Human%20cytotoxic%20T%20lymphocytes%20%28CTLs%29%20exhibit%20ultrarapid%20lytic%20granule%20secretion%2C%20but%20whether%20melanoma%20cells%20mobilize%20defense%20mechanisms%20with%20commensurate%20rapidity%20remains%20unknown.%20We%20used%20single-cell%20time-lapse%20microscopy%20to%20offer%20high%20spatiotemporal%20resolution%20analyses%20of%20subcellular%20events%20in%20melanoma%20cells%20upon%20CTL%20attack.%20Target%20cell%20perforation%20initiated%20an%20intracellular%20Ca2%2B%20wave%20that%20propagated%20outward%20from%20the%20synapse%20within%20milliseconds%20and%20triggered%20lysosomal%20mobilization%20to%20the%20synapse%2C%20facilitating%20membrane%20repair%20and%20conferring%20resistance%20to%20CTL%20induced%20cytotoxicity.%20Inhibition%20of%20Ca2%2B%20flux%20and%20silencing%20of%20synaptotagmin%20VII%20limited%20synaptic%20lysosomal%20exposure%20and%20enhanced%20cytotoxicity.%20Multiplexed%20immunohistochemistry%20of%20patient%20melanoma%20nodules%20combined%20with%20automated%20image%20analysis%20showed%20that%20melanoma%20cells%20facing%20CD8%2B%20CTLs%20in%20the%20tumor%20periphery%20or%20peritumoral%20area%20exhibited%20significant%20lysosomal%20enrichment.%20Our%20results%20identified%20synaptic%20Ca2%2B%20entry%20as%20the%20definitive%20trigger%20for%20lysosomal%20deployment%20to%20the%20synapse%20upon%20CTL%20attack%20and%20highlighted%20an%20unpredicted%20defensive%20topology%20of%20lysosome%20distribution%20in%20melanoma%20nodules.%22%2C%22date%22%3A%222022-02-18%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciadv.abk3234%22%2C%22ISSN%22%3A%222375-2548%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%2C%22UNNZZUAJ%22%5D%2C%22dateModified%22%3A%222023-01-04T10%3A19%3A27Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Shin, Sauyeun, Jacobo Solorzano, Mehdi Liauzun, Stéphane Pyronnet, Corinne Bousquet, and Yvan Martineau. “Translational Alterations in Pancreatic Cancer: A Central Role for the Integrated Stress Response.” NAR Cancer<\/i> 4, no. 4 (December 2022): zcac031. https:\/\/doi.org\/10.1093\/narcan\/zcac031<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Carrier, Arnaud, Cécile Desjobert, Valérie Lobjois, Lise Rigal, Florence Busato, Jörg Tost, Miquel Ensenyat-Mendez, et al. “Epigenetically Regulated PCDHB15 Impairs Aggressiveness of Metastatic Melanoma Cells.” Clinical Epigenetics<\/i> 14, no. 1 (November 28, 2022): 156. https:\/\/doi.org\/10.1186\/s13148-022-01364-x<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Carrier, Arnaud, Cécile Desjobert, Loic Ponger, Laurence Lamant, Matias Bustos, Jorge Torres-Ferreira, Rui Henrique, et al. “DNA Methylome Combined with Chromosome Cluster-Oriented Analysis Provides an Early Signature for Cutaneous Melanoma Aggressiveness.” ELife<\/i> 11 (September 20, 2022): e78587. https:\/\/doi.org\/10.7554\/eLife.78587<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Fuchs, Steffen, Loélia Babin, Elissa Andraos, Chloé Bessiere, Semjon Willier, Johannes H. Schulte, Christine Gaspin, and Fabienne Meggetto. “Generation of Full-Length Circular RNA Libraries for Oxford Nanopore Long-Read Sequencing.” PloS One<\/i> 17, no. 9 (September 7, 2022): e0273253. https:\/\/doi.org\/10.1371\/journal.pone.0273253<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Soulages, Antoine, Thierry Maisonobe, Pascal Auzou, Antoine Petit, Yves Allenbach, Stéphane Barète, Sophie Skopinski, et al. “Peripheral Neuropathy and Livedoid Vasculopathy.” Journal of Neurology<\/i> 269, no. 7 (July 2022): 3779–88. https:\/\/doi.org\/10.1007\/s00415-022-11007-z<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Darmon-Novello, Marie, Julien Adam, Laurence Lamant, Maxime Battistella, Nicolas Ortonne, Brigitte Balme, A. de la Fouchardière, et al. “Harmonization of Programmed Death-Ligand 1 Immunohistochemistry and MRNA Expression Scoring in Metastatic Melanoma: A Multicentre Analysis.” Histopathology<\/i> 80, no. 7 (June 2022): 1091–1101. https:\/\/doi.org\/10.1111\/his.14651<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Kervarrec, Thibault, Daniel Pissaloux, Jeremie Poilane, Franck Tirode, Anne Tallet, Christine Collin, Matthias Tallegas, et al. “Recurrent FOXK1::GRHL and GPS2::GRHL Fusions in Trichogerminoma.” The Journal of Pathology<\/i> 257, no. 1 (May 2022): 96–108. https:\/\/doi.org\/10.1002\/path.5872<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Vergnolle, Inès, Claudia Douat-Beyries, Serge Boulinguez, Jean-Baptiste Rieu, Jean-Philippe Vial, Rolande Baracou, Sylvie Boudot, et al. “CD158k and PD-1 Expressions Define Heterogeneous Subtypes of Sezary Syndrome.” Blood Advances<\/i> 6, no. 6 (March 22, 2022): 1813–25. https:\/\/doi.org\/10.1182\/bloodadvances.2021005147<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Babin, Loélia, Alice Darchen, Elie Robert, Zakia Aid, Rosalie Borry, Claire Soudais, Marion Piganeau, et al. “De Novo Generation of the NPM-ALK Fusion Recapitulates the Pleiotropic Phenotypes of ALK+ ALCL Pathogenesis and Reveals the ROR2 Receptor as Target for Tumor Cells.” Molecular Cancer<\/i> 21, no. 1 (March 4, 2022): 65. https:\/\/doi.org\/10.1186\/s12943-022-01520-0<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Battistella, Maxime, Brigitte Balme, Marie-Laure Jullie, Ute Zimmermann, Agnès Carlotti, Marie Crinquette, Eric Frouin, et al. “Impact of Expert Pathology Review in Skin Adnexal Carcinoma Diagnosis: Analysis of 2573 Patients from the French CARADERM Network.” European Journal of Cancer (Oxford, England: 1990)<\/i> 163 (March 2022): 211–21. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.027<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Filali, Liza, Marie-Pierre Puissegur, Kevin Cortacero, Sylvain Cussat-Blanc, Roxana Khazen, Nathalie Van Acker, François-Xavier Frenois, et al. “Ultrarapid Lytic Granule Release from CTLs Activates Ca2+-Dependent Synaptic Resistance Pathways in Melanoma Cells.” Science Advances<\/i> 8, no. 7 (February 18, 2022): eabk3234. https:\/\/doi.org\/10.1126\/sciadv.abk3234<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2021″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#ffffff” title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2021<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-030f97cf58dbb08bb8f9b36234fc1cd4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22R43PGR9F%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Babin%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBabin%2C%20Loelia%2C%20Elissa%20Andraos%2C%20Steffen%20Fuchs%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Erika%20Brunet%2C%20and%20Fabienne%20Meggetto.%20%26%23x201C%3BFrom%20CircRNAs%20to%20Fusion%20CircRNAs%20in%20Hematological%20Malignancies.%26%23x201D%3B%20%3Ci%3EJCI%20Insight%3C%5C%2Fi%3E%206%2C%20no.%2021%20%28November%208%2C%202021%29%3A%20e151513.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.151513%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.151513%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22From%20circRNAs%20to%20fusion%20circRNAs%20in%20hematological%20malignancies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loelia%22%2C%22lastName%22%3A%22Babin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elissa%22%2C%22lastName%22%3A%22Andraos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steffen%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Brunet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22Circular%20RNAs%20%28circRNAs%29%20represent%20a%20type%20of%20endogenous%20noncoding%20RNA%20generated%20by%20back-splicing%20events.%20Unlike%20the%20majority%20of%20RNAs%2C%20circRNAs%20are%20covalently%20closed%2C%20without%20a%205%27%20end%20or%20a%203%27%20poly%28A%29%20tail.%20A%20few%20circRNAs%20can%20be%20associated%20with%20polysomes%2C%20suggesting%20a%20protein-coding%20potential.%20CircRNAs%20are%20not%20degraded%20by%20RNA%20exonucleases%20or%20ribonuclease%20R%20and%20are%20enriched%20in%20exosomes.%20Recent%20developments%20in%20experimental%20methods%20coupled%20with%20evolving%20bioinformatic%20approaches%20have%20accelerated%20functional%20investigation%20of%20circRNAs%2C%20which%20exhibit%20a%20stable%20structure%2C%20a%20long%20half-life%2C%20and%20tumor%20specificity%20and%20can%20be%20extracted%20from%20body%20fluids%20and%20used%20as%20potential%20biological%20markers%20for%20tumors.%20Moreover%2C%20circRNAs%20may%20regulate%20the%20occurrence%20and%20development%20of%20cancers%20and%20contribute%20to%20drug%20resistance%20through%20a%20variety%20of%20molecular%20mechanisms.%20Despite%20the%20identification%20of%20a%20growing%20number%20of%20circRNAs%2C%20their%20effects%20in%20hematological%20cancers%20remain%20largely%20unknown.%20Recent%20studies%20indicate%20that%20circRNAs%20could%20also%20originate%20from%20fusion%20genes%20%28fusion%20circRNAs%2C%20f-circRNAs%29%20next%20to%20chromosomal%20translocations%2C%20which%20are%20considered%20the%20primary%20cause%20of%20various%20cancers%2C%20notably%20hematological%20malignancies.%20This%20Review%20will%20focus%20on%20circRNAs%20and%20f-circRNAs%20in%20hematological%20cancers.%22%2C%22date%22%3A%222021-11-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1172%5C%2Fjci.insight.151513%22%2C%22ISSN%22%3A%222379-3708%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222022-01-14T15%3A45%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22E72PZ9N6%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Camille%20et%20al.%22%2C%22parsedDate%22%3A%222021-11-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECamille%2C%20Daugrois%2C%20Bessiere%20Chlo%26%23xE9%3B%2C%20Dejean%20S%26%23xE9%3Bbastien%2C%20Anton%20Leberre%20V%26%23xE9%3Bronique%2C%20Commes%20Th%26%23xE9%3Br%26%23xE8%3Bse%2C%20Stephane%20Pyronnet%2C%20Pierre%20Brousset%2C%20et%20al.%20%26%23x201C%3BGene%20Expression%20Signature%20Associated%20with%20Clinical%20Outcome%20in%20ALK-Positive%20Anaplastic%20Large%20Cell%20Lymphoma.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2013%2C%20no.%2021%20%28November%203%2C%202021%29%3A%205523.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13215523%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13215523%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gene%20Expression%20Signature%20Associated%20with%20Clinical%20Outcome%20in%20ALK-Positive%20Anaplastic%20Large%20Cell%20Lymphoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daugrois%22%2C%22lastName%22%3A%22Camille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bessiere%22%2C%22lastName%22%3A%22Chlo%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dejean%22%2C%22lastName%22%3A%22S%5Cu00e9bastien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anton%20Leberre%22%2C%22lastName%22%3A%22V%5Cu00e9ronique%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Commes%22%2C%22lastName%22%3A%22Th%5Cu00e9r%5Cu00e8se%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Espinos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brugiere%22%2C%22lastName%22%3A%22Laurence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%5D%2C%22abstractNote%22%3A%22Anaplastic%20large%20cell%20lymphomas%20associated%20with%20ALK%20translocation%20have%20a%20good%20outcome%20after%20CHOP%20treatment%3B%20however%2C%20the%202-year%20relapse%20rate%20remains%20at%2030%25.%20Microarray%20gene-expression%20profiling%20of%2048%20samples%20obtained%20at%20diagnosis%20was%20used%20to%20identify%2047%20genes%20that%20were%20differentially%20expressed%20between%20patients%20with%20early%20relapse%5C%2Fprogression%20and%20no%20relapse.%20In%20the%20relapsing%20group%2C%20the%20most%20significant%20overrepresented%20genes%20were%20related%20to%20the%20regulation%20of%20the%20immune%20response%20and%20T-cell%20activation%20while%20those%20in%20the%20non-relapsing%20group%20were%20involved%20in%20the%20extracellular%20matrix.%20Fluidigm%20technology%20gave%20concordant%20results%20for%2029%20genes%2C%20of%20which%20FN1%2C%20FAM179A%2C%20and%20SLC40A1%20had%20the%20strongest%20predictive%20power%20after%20logistic%20regression%20and%20two%20classification%20algorithms.%20In%20parallel%20with%2039%20samples%2C%20we%20used%20a%20Kallisto%5C%2FSleuth%20pipeline%20to%20analyze%20RNA%20sequencing%20data%20and%20identified%2020%20genes%20common%20to%20the%2028%20genes%20validated%20by%20Fluidigm%20technology-notably%2C%20the%20FAM179A%20and%20FN1%20genes.%20Interestingly%2C%20FN1%20also%20belongs%20to%20the%20gene%20signature%20predicting%20longer%20survival%20in%20diffuse%20large%20B-cell%20lymphomas%20treated%20with%20CHOP.%20Thus%2C%20our%20molecular%20signatures%20indicate%20that%20the%20FN1%20gene%2C%20a%20matrix%20key%20regulator%2C%20might%20also%20be%20involved%20in%20the%20prognosis%20and%20the%20therapeutic%20response%20in%20anaplastic%20lymphomas.%22%2C%22date%22%3A%222021-11-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers13215523%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222022-01-14T15%3A50%3A00Z%22%7D%7D%2C%7B%22key%22%3A%228496F4MW%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gourvest%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGourvest%2C%20Morgane%2C%20Etienne%20De%20Clara%2C%20Hsin-Chieh%20Wu%2C%20Christian%20Touriol%2C%20Fabienne%20Meggetto%2C%20Hugues%20De%20Th%26%23xE9%3B%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Pierre%20Brousset%2C%20and%20Marina%20Bousquet.%20%26%23x201C%3BA%20Novel%20Leukemic%20Route%20of%20Mutant%20NPM1%20through%20Nuclear%20Import%20of%20the%20Overexpressed%20Long%20Noncoding%20RNA%20LONA.%26%23x201D%3B%20%3Ci%3ELeukemia%3C%5C%2Fi%3E%2035%2C%20no.%2010%20%28October%202021%29%3A%202784%26%23x2013%3B98.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01307-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41375-021-01307-0%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20novel%20leukemic%20route%20of%20mutant%20NPM1%20through%20nuclear%20import%20of%20the%20overexpressed%20long%20noncoding%20RNA%20LONA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Morgane%22%2C%22lastName%22%3A%22Gourvest%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22De%20Clara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hsin-Chieh%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Touriol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugues%22%2C%22lastName%22%3A%22De%20Th%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%22%2C%22lastName%22%3A%22Bousquet%22%7D%5D%2C%22abstractNote%22%3A%22The%20most%20frequent%20genetic%20alteration%20in%20acute%20myeloid%20leukemia%20%28AML%29%20is%20the%20mutation%20of%20nucleophosmin%201%20%28NPM1%29.%20Yet%2C%20its%20downstream%20oncogenic%20routes%20are%20not%20fully%20understood.%20Here%2C%20we%20report%20the%20identification%20of%20one%20long%20noncoding%20RNA%20%28lncRNA%29%20overexpressed%20in%20NPM1-mutated%20AML%20patients%20%28named%20LONA%29%20whose%20intracellular%20localization%20inversely%20reflects%20that%20of%20NPM1.%20While%20NPM1%20is%20nuclear%20and%20LONA%20cytoplasmic%20in%20wild-type%20NPM1%20AML%20cells%2C%20LONA%20becomes%20nuclear%20as%20mutant%20NPM1%20moves%20toward%20the%20cytoplasm.%20Gain%20or%20loss%20of%20function%20combined%20with%20a%20genome-wide%20RNA-seq%20search%20identified%20a%20set%20of%20LONA%20mRNA%20targets%20encoding%20proteins%20involved%20in%20myeloid%20cell%20differentiation%20%28including%20THSB1%2C%20MAFB%2C%20and%20ASB2%29%20and%20interaction%20with%20its%20microenvironment.%20Consistently%2C%20LONA%20overexpression%20in%20mutant%20NPM1%20established%20cell%20lines%20and%20primary%20AML%20cells%20exerts%20an%20anti-myeloid%20differentiation%20effect%2C%20whilst%20it%20exerts%20an%20opposite%20pro-myeloid%20differentiation%20effect%20in%20a%20wild%20type%20NPM1%20setting.%20In%20vivo%2C%20LONA%20overexpression%20acts%20as%20an%20oncogenic%20lncRNA%20reducing%20the%20survival%20of%20mice%20transplanted%20with%20AML%20cells%20and%20rendering%20AML%20tumors%20more%20resistant%20to%20AraC%20chemotherapy.These%20data%20indicate%20that%20mutation-dependent%20nuclear%20export%20of%20NPM1%20leads%20to%20nuclear%20retention%20and%20consequent%20oncogenic%20functions%20of%20the%20overexpressed%20lncRNA%20LONA%2C%20thus%20uncovering%20a%20novel%20NPM1%20mutation-dependent%20pathway%20in%20AML%20pathogenesis.%22%2C%22date%22%3A%222021-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41375-021-01307-0%22%2C%22ISSN%22%3A%221476-5551%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-11-22T16%3A41%3A10Z%22%7D%7D%2C%7B%22key%22%3A%224SDHTEN5%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alard%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAlard%2C%20Amandine%2C%20Manon%20Streha%26%23xEF%3Bano%2C%20David%20M%26%23xFC%3Bller%2C%20Charline%20Lasfargues%2C%20St%26%23xE9%3Bphanie%20Cassant-Sourdy%2C%20Christine%20Jean%2C%20Corinne%20Bousquet%2C%20Yvan%20Martineau%2C%20and%20St%26%23xE9%3Bphane%20Pyronnet.%20%26%23x201C%3BPhosphorylation%20of%20the%20MNK1%20Substrate%20EIF4E%20Is%20Not%20Required%20for%20Response%20to%20Acute%20Pancreatitis.%26%23x201D%3B%20%3Ci%3EPancreatology%3A%20Official%20Journal%20of%20the%20International%20Association%20of%20Pancreatology%20%28IAP%29%20...%20%5Bet%20Al.%5D%3C%5C%2Fi%3E%2021%2C%20no.%204%20%28June%202021%29%3A%20677%26%23x2013%3B81.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.pan.2021.02.013%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.pan.2021.02.013%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Phosphorylation%20of%20the%20MNK1%20substrate%20eIF4E%20is%20not%20required%20for%20response%20to%20acute%20pancreatitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amandine%22%2C%22lastName%22%3A%22Alard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Streha%5Cu00efano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charline%22%2C%22lastName%22%3A%22Lasfargues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Cassant-Sourdy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20MNK1%20protein%20kinase%20is%20directly%20activated%20by%20the%20MAPK%20pathway%20and%20is%20specifically%20expressed%20in%20pancreatic%20acinar%20cells.%20Both%20the%20MNK1%20kinase%20and%20the%20MAPK%20pathway%20are%20required%20for%20response%20to%20pancreatitis%2C%20suggesting%20that%20their%20pharmacological%20targeting%20would%20be%20of%20therapeutic%20interest.%20Because%20the%20mRNA%20cap-binding%20protein%20and%20translation%20initiation%20factor%20eIF4E%20is%20the%20major%20known%20MNK1%20substrate%2C%20one%20could%20anticipate%20that%20the%20protective%20function%20of%20MNK1%20in%20pancreatitis%20is%20mediated%20by%20eIF4E%20phosphorylation.%5CnMETHODS%3A%20Acute%20pancreatitis%20was%20induced%20by%20the%20intraperitoneal%20administration%20of%20cerulein%20in%20wild-type%20mice%20and%20in%20transgenic%20mice%20carrying%20two%20non-phosphorylatable%20Eif4e%20alleles.%20The%20expression%20and%20phosphorylation%20of%20proteins%20of%20the%20MNK1-eIF4E%20pathway%20was%20visualized%20by%20western-blotting.%20The%20severity%20of%20pancreatitis%20was%20monitored%20by%20the%20measure%20of%20serum%20amylase%20levels%20and%20by%20histopathology%20and%20immunohistochemistry%20using%20apoptosis%20and%20immune%20infiltrate%20markers.%5CnRESULTS%3A%20Despite%20a%20strong%20induction%20in%20MNK1%20kinase%20activity%20in%20both%20wild-type%20and%20transgenic%20mice%2C%20precluding%20eIF4E%20phosphorylation%20has%20no%20impact%20on%20the%20severity%20of%20acute%20pancreatitis.%20Serum%20amylase%20is%20equally%20induced%20in%20both%20mouse%20genotypes%20and%20neither%20acinar%20cell%20apoptosis%20nor%20immune%20infiltrate%20is%20exacerbated.%5CnCONCLUSION%3A%20eIF4E%20phosphorylation%20is%20not%20required%20for%20response%20to%20pancreatitis%20indicating%20that%20the%20acinar-cell-specific%20MNK1%20kinase%20acts%20in%20acute%20pancreatitis%20via%20another%20substrate.%22%2C%22date%22%3A%222021-06%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.pan.2021.02.013%22%2C%22ISSN%22%3A%221424-3911%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-10-11T11%3A20%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22ASEHR4MC%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Syrykh%20et%20al.%22%2C%22parsedDate%22%3A%222021-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESyrykh%2C%20Charlotte%2C%20Lo%26%23xEF%3Bc%20Ysebaert%2C%20Sarah%20P%26%23xE9%3Bricart%2C%20Sol%26%23xE8%3Bne%20M.%20Evrard%2C%20Fabienne%20Meggetto%2C%20Salim%20Kanoun%2C%20Pierre%20Brousset%2C%20and%20Camille%20Laurent.%20%26%23x201C%3BALK-Positive%20Histiocytosis%20Associated%20with%20Chronic%20Lymphocytic%20Leukaemia%5C%2FSmall%20Lymphocytic%20Lymphoma%3A%20A%20Multitarget%20Response%20under%20Ibrutinib.%26%23x201D%3B%20%3Ci%3EVirchows%20Archiv%3A%20An%20International%20Journal%20of%20Pathology%3C%5C%2Fi%3E%20478%2C%20no.%204%20%28April%202021%29%3A%20779%26%23x2013%3B83.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00428-020-02937-y%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00428-020-02937-y%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ALK-positive%20histiocytosis%20associated%20with%20chronic%20lymphocytic%20leukaemia%5C%2Fsmall%20lymphocytic%20lymphoma%3A%20a%20multitarget%20response%20under%20ibrutinib%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Syrykh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lo%5Cu00efc%22%2C%22lastName%22%3A%22Ysebaert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22P%5Cu00e9ricart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sol%5Cu00e8ne%20M.%22%2C%22lastName%22%3A%22Evrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%22%2C%22lastName%22%3A%22Kanoun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Laurent%22%7D%5D%2C%22abstractNote%22%3A%22ALK-positive%20histiocytosis%20is%20a%20recently%20described%20entity%20with%20few%20reported%20cases%20in%20literature.%20Herein%2C%20we%20report%20an%20unusual%20case%20of%20ALK-positive%20histiocytosis%20showing%20an%20Erdheim-Chester%20disease%20%28ECD%29-like%20presentation%2C%20occurring%20in%20a%2037-year-old%20woman%20with%20a%202-year%20history%20of%20chronic%20lymphocytic%20leukaemia%20%28CLL%29.%20Our%20CLL%20patient%20relapsed%206%5Cu00a0months%20after%20the%20end%20of%20fludarabine%2C%20cyclophosphamide%20and%20rituximab%20frontline%20therapy%20and%20complained%20of%20lower%20limb%20pains.%20A%20bone%20marrow%20biopsy%20was%20performed%20and%20showed%20concomitant%20CLL%5C%2Fsmall%20lymphocytic%20lymphoma%20and%20ALK-positive%20histiocytosis%20with%20an%20identical%20immunoglobulin%20heavy-chain%20gene%20rearrangement%20in%20both%20neoplasms%2C%20suggesting%20clonal%20relationship.%20After%204%5Cu00a0years%20under%20ibrutinib%20therapy%2C%20our%20patient%20remains%20free%20of%20both%20diseases.%20This%20report%20extends%20the%20spectrum%20of%20composite%20hematolymphoid%20neoplasms%20and%20shows%20that%20ALK%20rearrangement%20should%20be%20considered%20in%20all%20histiocytosis%20subtypes.%20Moreover%2C%20both%20tumours%20eradication%20under%20ibrutinib%20suggests%20that%20BTK%20inhibitors%20may%20also%20be%20effective%20in%20histiocytic%20neoplasms.%22%2C%22date%22%3A%222021-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00428-020-02937-y%22%2C%22ISSN%22%3A%221432-2307%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22QS3I9WIA%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-16T13%3A51%3A16Z%22%7D%7D%2C%7B%22key%22%3A%225RFG27R3%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22F%5Cu00e9ral%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EF%26%23xE9%3Bral%2C%20Kelly%2C%20Manon%20Jaud%2C%20C%26%23xE9%3Bline%20Philippe%2C%20Doriana%20Di%20Bella%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Kevin%20Rouault-Pierre%2C%20Laurent%20Mazzolini%2C%20and%20Christian%20Touriol.%20%26%23x201C%3BER%20Stress%20and%20Unfolded%20Protein%20Response%20in%20Leukemia%3A%20Friend%2C%20Foe%2C%20or%20Both%3F%26%23x201D%3B%20%3Ci%3EBiomolecules%3C%5C%2Fi%3E%2011%2C%20no.%202%20%28January%2030%2C%202021%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fbiom11020199%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fbiom11020199%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ER%20Stress%20and%20Unfolded%20Protein%20Response%20in%20Leukemia%3A%20Friend%2C%20Foe%2C%20or%20Both%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22F%5Cu00e9ral%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Jaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Philippe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doriana%22%2C%22lastName%22%3A%22Di%20Bella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Rouault-Pierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Mazzolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Touriol%22%7D%5D%2C%22abstractNote%22%3A%22The%20unfolded%20protein%20response%20%28UPR%29%20is%20an%20evolutionarily%20conserved%20adaptive%20signaling%20pathway%20triggered%20by%20a%20stress%20of%20the%20endoplasmic%20reticulum%20%28ER%29%20lumen%20compartment%2C%20which%20is%20initiated%20by%20the%20accumulation%20of%20unfolded%20proteins.%20This%20response%2C%20mediated%20by%20three%20sensors-Inositol%20Requiring%20Enzyme%201%20%28IRE1%29%2C%20Activating%20Transcription%20Factor%206%20%28ATF6%29%2C%20and%20Protein%20Kinase%20RNA-Like%20Endoplasmic%20Reticulum%20Kinase%20%28PERK%29-allows%20restoring%20protein%20homeostasis%20and%20maintaining%20cell%20survival.%20UPR%20represents%20a%20major%20cytoprotective%20signaling%20network%20for%20cancer%20cells%2C%20which%20frequently%20experience%20disturbed%20proteostasis%20owing%20to%20their%20rapid%20proliferation%20in%20an%20usually%20unfavorable%20microenvironment.%20Increased%20basal%20UPR%20also%20participates%20in%20the%20resistance%20of%20tumor%20cells%20against%20chemotherapy.%20UPR%20activation%20also%20occurs%20during%20hematopoiesis%2C%20and%20growing%20evidence%20supports%20the%20critical%20cytoprotective%20role%20played%20by%20ER%20stress%20in%20the%20emergence%20and%20proliferation%20of%20leukemic%20cells.%20In%20case%20of%20severe%20or%20prolonged%20stress%2C%20pro-survival%20UPR%20may%20however%20evolve%20into%20a%20cell%20death%20program%20called%20terminal%20UPR.%20Interestingly%2C%20a%20large%20number%20of%20studies%20have%20revealed%20that%20the%20induction%20of%20proapoptotic%20UPR%20can%20also%20strongly%20contribute%20to%20the%20sensitization%20of%20leukemic%20cells%20to%20chemotherapy.%20Here%2C%20we%20review%20the%20current%20knowledge%20on%20the%20consequences%20of%20the%20deregulation%20of%20UPR%20signaling%20in%20leukemias%20and%20their%20implications%20for%20the%20treatment%20of%20these%20diseases.%22%2C%22date%22%3A%222021-01-30%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fbiom11020199%22%2C%22ISSN%22%3A%222218-273X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-10-18T13%3A01%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22Y676MPP2%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Andraos%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-05%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAndraos%2C%20Elissa%2C%20Jos%26%23xE9%3Bphine%20Dignac%2C%20and%20Fabienne%20Meggetto.%20%26%23x201C%3BNPM-ALK%3A%20A%20Driver%20of%20Lymphoma%20Pathogenesis%20and%20a%20Therapeutic%20Target.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2013%2C%20no.%201%20%28January%205%2C%202021%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13010144%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers13010144%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22NPM-ALK%3A%20A%20Driver%20of%20Lymphoma%20Pathogenesis%20and%20a%20Therapeutic%20Target%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elissa%22%2C%22lastName%22%3A%22Andraos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9phine%22%2C%22lastName%22%3A%22Dignac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22Initially%20discovered%20in%20anaplastic%20large%20cell%20lymphoma%20%28ALCL%29%2C%20the%20ALK%20anaplastic%20lymphoma%20kinase%20is%20a%20tyrosine%20kinase%20which%20is%20affected%20in%20lymphomas%20by%20oncogenic%20translocations%2C%20mainly%20NPM-ALK.%20To%20date%2C%20chemotherapy%20remains%20a%20viable%20option%20in%20ALCL%20patients%20with%20ALK%20translocations%20as%20it%20leads%20to%20remission%20rates%20of%20approximately%2080%25.%20However%2C%20the%20remaining%20patients%20do%20not%20respond%20to%20chemotherapy%20and%20some%20patients%20have%20drug-resistant%20relapses.%20It%20is%20therefore%20crucial%20to%20identify%20new%20and%20better%20treatment%20options.%20Nowadays%2C%20different%20classes%20of%20ALK%20tyrosine%20kinase%20inhibitors%20%28TKI%29%20are%20available%20and%20used%20exclusively%20for%20EML4-ALK%20%28%2B%29%20lung%20cancers.%20In%20fact%2C%20the%20significant%20toxicities%20of%20most%20ALK%20inhibitors%20explain%20the%20delay%20in%20their%20use%20in%20ALCL%20patients%2C%20who%20are%20predominantly%20children.%20Moreover%2C%20some%20ALCL%20patients%20do%20not%20respond%20to%20Crizotinib%2C%20the%20first%20generation%20TKI%2C%20or%20develop%20an%20acquired%20resistance%20months%20following%20an%20initial%20response.%20Combination%20therapy%20with%20ALK%20inhibitors%20in%20ALCL%20is%20the%20current%20challenge.%22%2C%22date%22%3A%222021-01-05%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers13010144%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-16T13%3A59%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22P5E3JQ68%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Samain%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESamain%2C%20R%26%23xE9%3Bmi%2C%20Alexia%20Brunel%2C%20Thibault%20Douch%26%23xE9%3B%2C%20Marjorie%20Fanjul%2C%20St%26%23xE9%3Bphanie%20Cassant-Sourdy%2C%20Julia%20Rochotte%2C%20J%26%23xE9%3Br%26%23xF4%3Bme%20Cros%2C%20et%20al.%20%26%23x201C%3BPharmacologic%20Normalization%20of%20Pancreatic%20Cancer-Associated%20Fibroblast%20Secretome%20Impairs%20Prometastatic%20Cross-Talk%20With%20Macrophages.%26%23x201D%3B%20%3Ci%3ECellular%20and%20Molecular%20Gastroenterology%20and%20Hepatology%3C%5C%2Fi%3E%2011%2C%20no.%205%20%282021%29%3A%201405%26%23x2013%3B36.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcmgh.2021.01.008%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcmgh.2021.01.008%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacologic%20Normalization%20of%20Pancreatic%20Cancer-Associated%20Fibroblast%20Secretome%20Impairs%20Prometastatic%20Cross-Talk%20With%20Macrophages%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9mi%22%2C%22lastName%22%3A%22Samain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexia%22%2C%22lastName%22%3A%22Brunel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibault%22%2C%22lastName%22%3A%22Douch%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjorie%22%2C%22lastName%22%3A%22Fanjul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Cassant-Sourdy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Rochotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Cros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cindy%22%2C%22lastName%22%3A%22Neuzillet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Raffenne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Duluc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Perraud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00e9my%22%2C%22lastName%22%3A%22Nigri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9ronique%22%2C%22lastName%22%3A%22Gigoux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Bieche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Ponzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Carpentier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Cascone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Tomasini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herbert%20A.%22%2C%22lastName%22%3A%22Schmid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muriel%22%2C%22lastName%22%3A%22Mathonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9my%22%2C%22lastName%22%3A%22Nicolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Pierre%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%20%26%20AIMS%3A%20Cancer-associated%20fibroblasts%20%28CAFs%29%20from%20pancreatic%20adenocarcinoma%20%28PDA%29%20present%20high%20protein%20synthesis%20rates.%20CAFs%20express%20the%20G-protein-coupled%20somatostatin%20receptor%20sst1.%20The%20sst1%20agonist%20SOM230%20blocks%20CAF%20protumoral%20features%20in%5Cu00a0vitro%20and%20in%20immunocompromised%20mice.%20We%20have%20explored%20here%20the%20therapeutic%20potential%20of%20SOM230%2C%20and%20underlying%20mechanisms%2C%20in%20immunocompetent%20models%20of%20murine%20PDA%20mimicking%20the%20heavy%20fibrotic%20and%20immunosuppressive%20stroma%20observed%20in%20patient%20tumors.%5CnMETHODS%3A%20Large-scale%20mass%20spectrometry%20analyses%20were%20performed%20on%20media%20conditioned%20from%209%20patient%20PDA-derived%20CAF%20primary%20cultures.%20Spontaneous%20transgenic%20and%20experimental%20%28orthotopic%20co-graft%20of%20tumor%20cells%20plus%20CAFs%29%20PDA-bearing%20mice%20were%20longitudinally%20ultrasound-monitored%20for%20tumor%20and%20metastatic%20progression.%20Histopathology%20and%20flow%20cytometry%20analyses%20were%20performed%20on%20primary%20tumors%20and%20metastases.%20Stromal%20signatures%20were%20functionally%20validated%20through%20bioinformatics%20using%20several%20published%2C%20and%201%20original%2C%20PDA%20database.%5CnRESULTS%3A%20Proteomics%20on%20the%20CAF%20secretome%20showed%20that%20SOM230%20controls%20stromal%20activities%20including%20inflammatory%20responses.%20Among%20the%20identified%20secreted%20proteins%2C%20we%20validated%20that%20colony-stimulating%20factor%201%20%28CSF-1%29%20%28a%20macrophage%20growth%20factor%29%20was%20reduced%20by%20SOM230%20in%20the%20tumor%20and%20plasma%20of%20PDA-harboring%20mice%2C%20alongside%20intratumor%20stromal%20normalization%20%28reduced%20CAF%20and%20macrophage%20activities%29%2C%20and%20dramatic%20metastasis%20reduction.%20In%20transgenic%20mice%2C%20these%20SOM230%20benefits%20alleviate%20the%20chemotherapy-induced%20%28gemcitabine%29%20immunosuppressive%20stroma%20reshaping.%20Mechanistically%2C%20SOM230%20acts%20in%5Cu00a0vivo%20on%20CAFs%20through%20sst1%20to%20disrupt%20prometastatic%20CAF%20production%20of%20CSF-1%20and%20cross-talk%20with%20macrophages.%20We%20found%20that%20in%20patients%2C%20stromal%20CSF-1%20was%20associated%20with%20aggressive%20PDA%20forms.%5CnCONCLUSIONS%3A%20We%20propose%20SOM230%20as%20an%20antimetastatic%20therapy%20in%20PDA%20for%20its%20capacity%20to%20remodel%20the%20fibrotic%20and%20immunosuppressive%20myeloid%20stroma.%20This%20pharmacotherapy%20should%20benefit%20PDA%20patients%20treated%20with%20chemotherapies.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcmgh.2021.01.008%22%2C%22ISSN%22%3A%222352-345X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-16T14%3A00%3A27Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Babin, Loelia, Elissa Andraos, Steffen Fuchs, Stéphane Pyronnet, Erika Brunet, and Fabienne Meggetto. “From CircRNAs to Fusion CircRNAs in Hematological Malignancies.” JCI Insight<\/i> 6, no. 21 (November 8, 2021): e151513. https:\/\/doi.org\/10.1172\/jci.insight.151513<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Camille, Daugrois, Bessiere Chloé, Dejean Sébastien, Anton Leberre Véronique, Commes Thérèse, Stephane Pyronnet, Pierre Brousset, et al. “Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma.” Cancers<\/i> 13, no. 21 (November 3, 2021): 5523. https:\/\/doi.org\/10.3390\/cancers13215523<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Gourvest, Morgane, Etienne De Clara, Hsin-Chieh Wu, Christian Touriol, Fabienne Meggetto, Hugues De Thé, Stéphane Pyronnet, Pierre Brousset, and Marina Bousquet. “A Novel Leukemic Route of Mutant NPM1 through Nuclear Import of the Overexpressed Long Noncoding RNA LONA.” Leukemia<\/i> 35, no. 10 (October 2021): 2784–98. https:\/\/doi.org\/10.1038\/s41375-021-01307-0<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Alard, Amandine, Manon Strehaïano, David Müller, Charline Lasfargues, Stéphanie Cassant-Sourdy, Christine Jean, Corinne Bousquet, Yvan Martineau, and Stéphane Pyronnet. “Phosphorylation of the MNK1 Substrate EIF4E Is Not Required for Response to Acute Pancreatitis.” Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]<\/i> 21, no. 4 (June 2021): 677–81. https:\/\/doi.org\/10.1016\/j.pan.2021.02.013<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Syrykh, Charlotte, Loïc Ysebaert, Sarah Péricart, Solène M. Evrard, Fabienne Meggetto, Salim Kanoun, Pierre Brousset, and Camille Laurent. “ALK-Positive Histiocytosis Associated with Chronic Lymphocytic Leukaemia\/Small Lymphocytic Lymphoma: A Multitarget Response under Ibrutinib.” Virchows Archiv: An International Journal of Pathology<\/i> 478, no. 4 (April 2021): 779–83. https:\/\/doi.org\/10.1007\/s00428-020-02937-y<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Féral, Kelly, Manon Jaud, Céline Philippe, Doriana Di Bella, Stéphane Pyronnet, Kevin Rouault-Pierre, Laurent Mazzolini, and Christian Touriol. “ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?” Biomolecules<\/i> 11, no. 2 (January 30, 2021). https:\/\/doi.org\/10.3390\/biom11020199<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Andraos, Elissa, Joséphine Dignac, and Fabienne Meggetto. “NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target.” Cancers<\/i> 13, no. 1 (January 5, 2021). https:\/\/doi.org\/10.3390\/cancers13010144<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Samain, Rémi, Alexia Brunel, Thibault Douché, Marjorie Fanjul, Stéphanie Cassant-Sourdy, Julia Rochotte, Jérôme Cros, et al. “Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.” Cellular and Molecular Gastroenterology and Hepatology<\/i> 11, no. 5 (2021): 1405–36. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.01.008<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2020″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#505659″ title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_font=”|600|||||||” closed_title_text_align=”center” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2020<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-46c52cec88b33dcc2641af4d85a7f39f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22LSBQH7EF%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Congras%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECongras%2C%20Annabelle%2C%20Coralie%20Hoareau-Aveilla%2C%20Nina%20Caillet%2C%20Marie%20Tosolini%2C%20Patrick%20Villarese%2C%20Agata%20Cieslak%2C%20Laura%20Rodriguez%2C%20et%20al.%20%26%23x201C%3BALK-Transformed%20Mature%20T%20Lymphocytes%20Restore%20Early%20Thymus%20Progenitor%20Features.%26%23x201D%3B%20%3Ci%3EJournal%20of%20Clinical%20Investigation%3C%5C%2Fi%3E%2C%20November%203%2C%202020%2C%2010.1172%5C%2FJCI134990.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI134990%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI134990%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ALK-transformed%20mature%20T%20lymphocytes%20restore%20early%20thymus%20progenitor%20features%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Congras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Coralie%22%2C%22lastName%22%3A%22Hoareau-Aveilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nina%22%2C%22lastName%22%3A%22Caillet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Tosolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Villarese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agata%22%2C%22lastName%22%3A%22Cieslak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vahid%22%2C%22lastName%22%3A%22Asnafi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Macintyre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerda%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-11-3%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1172%5C%2FJCI134990%22%2C%22ISSN%22%3A%220021-9738%2C%201558-8238%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.jci.org%5C%2Farticles%5C%2Fview%5C%2F134990%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A48Z%22%7D%7D%2C%7B%22key%22%3A%226N2ACXIX%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sorrentino%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-13%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESorrentino%2C%20Domenico%2C%20Julie%20Frentzel%2C%20G%26%23xE9%3Braldine%20Mitou%2C%20Rafael%20B.%20Blasco%2C%20Av%26%23xE9%3Bdis%20Torossian%2C%20Coralie%20Hoareau-Aveilla%2C%20Chiara%20Pighi%2C%20et%20al.%20%26%23x201C%3BHigh%20Levels%20of%20MiR-7-5p%20Potentiate%20Crizotinib-Induced%20Cytokilling%20and%20Autophagic%20Flux%20by%20Targeting%20RAF1%20in%20NPM-ALK%20Positive%20Lymphoma%20Cells.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2012%2C%20no.%2010%20%28October%2013%2C%202020%29%3A%202951.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers12102951%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers12102951%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High%20Levels%20of%20miR-7-5p%20Potentiate%20Crizotinib-Induced%20Cytokilling%20and%20Autophagic%20Flux%20by%20Targeting%20RAF1%20in%20NPM-ALK%20Positive%20Lymphoma%20Cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Domenico%22%2C%22lastName%22%3A%22Sorrentino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Frentzel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00e9raldine%22%2C%22lastName%22%3A%22Mitou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%20B.%22%2C%22lastName%22%3A%22Blasco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Av%5Cu00e9dis%22%2C%22lastName%22%3A%22Torossian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Coralie%22%2C%22lastName%22%3A%22Hoareau-Aveilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Pighi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Farc%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Manenti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Espinos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Chiarle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Giuriato%22%7D%5D%2C%22abstractNote%22%3A%22Anaplastic%20lymphoma%20kinase%20positive%20anaplastic%20large%20cell%20lymphomas%20%28ALK%2B%20ALCL%29%20are%20an%20aggressive%20pediatric%20disease.%20The%20therapeutic%20options%20comprise%20chemotherapy%2C%20which%20is%20efficient%20in%20approximately%2070%25%20of%20patients%2C%20and%20targeted%20therapies%2C%20such%20as%20crizotinib%20%28an%20ALK%20tyrosine%20kinase%20inhibitor%20%28TKI%29%29%2C%20used%20in%20refractory%5C%2Frelapsed%20cases.%20Research%20efforts%20have%20also%20converged%20toward%20the%20development%20of%20combined%20therapies%20to%20improve%20treatment.%20In%20this%20context%2C%20we%20studied%20whether%20autophagy%20could%20be%20modulated%20to%20improve%20crizotinib%20therapy.%20Autophagy%20is%20a%20vesicular%20recycling%20pathway%2C%20known%20to%20be%20associated%20with%20either%20cell%20survival%20or%20cell%20death%20depending%20on%20the%20cancer%20and%20therapy.%20We%20previously%20demonstrated%20that%20crizotinib%20induced%20cytoprotective%20autophagy%20in%20ALK%2B%20lymphoma%20cells%20and%20that%20its%20further%20intensification%20was%20associated%20with%20cell%20death.%20In%20line%20with%20these%20results%2C%20we%20show%20here%20that%20combined%20ALK%20and%20Rapidly%20Accelerated%20Fibrosarcoma%201%20%28RAF1%29%20inhibition%2C%20using%20pharmacological%20%28vemurafenib%29%20or%20molecular%20%28small%20interfering%20RNA%20targeting%20RAF1%20%28siRAF1%29%20or%20microRNA-7-5p%20%28miR-7-5p%29%20mimics%29%20strategies%2C%20also%20triggered%20autophagy%20and%20potentiated%20the%20toxicity%20of%20TKI.%20Mechanistically%2C%20we%20found%20that%20this%20combined%20therapy%20resulted%20in%20the%20decrease%20of%20the%20inhibitory%20phosphorylation%20on%20Unc-51-like%20kinase-1%20%28ULK1%29%20%28a%20key%20protein%20in%20autophagy%20initiation%29%2C%20which%20may%20account%20for%20the%20enforced%20autophagy%20and%20cytokilling%20effect.%20Altogether%2C%20our%20results%20support%20the%20development%20of%20ALK%20and%20RAF1%20combined%20inhibition%20as%20a%20new%20therapeutic%20approach%20in%20ALK%2B%20ALCL.%22%2C%22date%22%3A%222020-10-13%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers12102951%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2072-6694%5C%2F12%5C%2F10%5C%2F2951%22%2C%22collections%22%3A%5B%22WVCHCN8C%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22YP95H5F4%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zaghdoudi%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZaghdoudi%2C%20Sonia%2C%20Emilie%20Decaup%2C%20Ismahane%20Belhabib%2C%20R%26%23xE9%3Bmi%20Samain%2C%20St%26%23xE9%3Bphanie%20Cassant%26%23x2010%3BSourdy%2C%20Julia%20Rochotte%2C%20Alexia%20Brunel%2C%20et%20al.%20%26%23x201C%3BActivity%20in%20Cancer%26%23x2010%3Bassociated%20Fibroblasts%20Is%20a%20Prognostic%20Marker%20and%20a%20Druggable%20Key%20Metastatic%20Player%20in%20Pancreatic%20Cancer.%26%23x201D%3B%20%3Ci%3EEMBO%20Molecular%20Medicine%3C%5C%2Fi%3E%2C%20October%207%2C%202020.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15252%5C%2Femmm.202012010%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.15252%5C%2Femmm.202012010%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Activity%20in%20cancer%5Cu2010associated%20fibroblasts%20is%20a%20prognostic%20marker%20and%20a%20druggable%20key%20metastatic%20player%20in%20pancreatic%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonia%22%2C%22lastName%22%3A%22Zaghdoudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Decaup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ismahane%22%2C%22lastName%22%3A%22Belhabib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9mi%22%2C%22lastName%22%3A%22Samain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Cassant%5Cu2010Sourdy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Rochotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexia%22%2C%22lastName%22%3A%22Brunel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schlaepfer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9rome%22%2C%22lastName%22%3A%22Cros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cindy%22%2C%22lastName%22%3A%22Neuzillet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Strehaiano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amandine%22%2C%22lastName%22%3A%22Alard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Tomasini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vinothini%22%2C%22lastName%22%3A%22Rajeeve%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Perraud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muriel%22%2C%22lastName%22%3A%22Mathonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%20MT%22%2C%22lastName%22%3A%22Pearce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Jean%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-10-07%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.15252%5C%2Femmm.202012010%22%2C%22ISSN%22%3A%221757-4676%2C%201757-4684%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2F10.15252%5C%2Femmm.202012010%22%2C%22collections%22%3A%5B%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A36%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22UYDHJTYW%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaud%20et%20al.%22%2C%22parsedDate%22%3A%222020-02-26%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJaud%2C%20Manon%2C%20C%26%23xE9%3Bline%20Philippe%2C%20Doriana%20Di%20Bella%2C%20Weiwei%20Tang%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Henrik%20Laurell%2C%20Laurent%20Mazzolini%2C%20Kevin%20Rouault-Pierre%2C%20and%20Christian%20Touriol.%20%26%23x201C%3BTranslational%20Regulations%20in%20Response%20to%20Endoplasmic%20Reticulum%20Stress%20in%20Cancers.%26%23x201D%3B%20%3Ci%3ECells%3C%5C%2Fi%3E%209%2C%20no.%203%20%28February%2026%2C%202020%29%3A%20540.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells9030540%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcells9030540%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Translational%20Regulations%20in%20Response%20to%20Endoplasmic%20Reticulum%20Stress%20in%20Cancers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Jaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Philippe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doriana%22%2C%22lastName%22%3A%22Di%20Bella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weiwei%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Laurell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Mazzolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Rouault-Pierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Touriol%22%7D%5D%2C%22abstractNote%22%3A%22During%20carcinogenesis%2C%20almost%20all%20the%20biological%20processes%20are%20modified%20in%20one%20way%20or%20another.%20Among%20these%20biological%20processes%20affected%2C%20anomalies%20in%20protein%20synthesis%20are%20common%20in%20cancers.%20Indeed%2C%20cancer%20cells%20are%20subjected%20to%20a%20wide%20range%20of%20stresses%2C%20which%20include%20physical%20injuries%2C%20hypoxia%2C%20nutrient%20starvation%2C%20as%20well%20as%20mitotic%2C%20oxidative%20or%20genotoxic%20stresses.%20All%20of%20these%20stresses%20will%20cause%20the%20accumulation%20of%20unfolded%20proteins%20in%20the%20Endoplasmic%20Reticulum%20%28ER%29%2C%20which%20is%20a%20major%20organelle%20that%20is%20involved%20in%20protein%20synthesis%2C%20preservation%20of%20cellular%20homeostasis%2C%20and%20adaptation%20to%20unfavourable%20environment.%20The%20accumulation%20of%20unfolded%20proteins%20in%20the%20endoplasmic%20reticulum%20causes%20stress%20triggering%20an%20unfolded%20protein%20response%20in%20order%20to%20promote%20cell%20survival%20or%20to%20induce%20apoptosis%20in%20case%20of%20chronic%20stress.%20Transcription%20and%20also%20translational%20reprogramming%20are%20tightly%20controlled%20during%20the%20unfolded%20protein%20response%20to%20ensure%20selective%20gene%20expression.%20The%20majority%20of%20stresses%2C%20including%20ER%20stress%2C%20induce%20firstly%20a%20decrease%20in%20global%20protein%20synthesis%20accompanied%20by%20the%20induction%20of%20alternative%20mechanisms%20for%20initiating%20the%20translation%20of%20mRNA%2C%20later%20followed%20by%20a%20translational%20recovery.%20After%20a%20presentation%20of%20ER%20stress%20and%20the%20UPR%20response%2C%20we%20will%20briefly%20present%20the%20different%20modes%20of%20translation%20initiation%2C%20then%20address%20the%20specific%20translational%20regulatory%20mechanisms%20acting%20during%20reticulum%20stress%20in%20cancers%20and%20highlight%20the%20importance%20of%20translational%20control%20by%20ER%20stress%20in%20tumours.%22%2C%22date%22%3A%222020-02-26%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fcells9030540%22%2C%22ISSN%22%3A%222073-4409%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2073-4409%5C%2F9%5C%2F3%5C%2F540%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-06-14T14%3A21%3A28Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Congras, Annabelle, Coralie Hoareau-Aveilla, Nina Caillet, Marie Tosolini, Patrick Villarese, Agata Cieslak, Laura Rodriguez, et al. “ALK-Transformed Mature T Lymphocytes Restore Early Thymus Progenitor Features.” Journal of Clinical Investigation<\/i>, November 3, 2020, 10.1172\/JCI134990. https:\/\/doi.org\/10.1172\/JCI134990<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Sorrentino, Domenico, Julie Frentzel, Géraldine Mitou, Rafael B. Blasco, Avédis Torossian, Coralie Hoareau-Aveilla, Chiara Pighi, et al. “High Levels of MiR-7-5p Potentiate Crizotinib-Induced Cytokilling and Autophagic Flux by Targeting RAF1 in NPM-ALK Positive Lymphoma Cells.” Cancers<\/i> 12, no. 10 (October 13, 2020): 2951. https:\/\/doi.org\/10.3390\/cancers12102951<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Zaghdoudi, Sonia, Emilie Decaup, Ismahane Belhabib, Rémi Samain, Stéphanie Cassant‐Sourdy, Julia Rochotte, Alexia Brunel, et al. “Activity in Cancer‐associated Fibroblasts Is a Prognostic Marker and a Druggable Key Metastatic Player in Pancreatic Cancer.” EMBO Molecular Medicine<\/i>, October 7, 2020. https:\/\/doi.org\/10.15252\/emmm.202012010<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Jaud, Manon, Céline Philippe, Doriana Di Bella, Weiwei Tang, Stéphane Pyronnet, Henrik Laurell, Laurent Mazzolini, Kevin Rouault-Pierre, and Christian Touriol. “Translational Regulations in Response to Endoplasmic Reticulum Stress in Cancers.” Cells<\/i> 9, no. 3 (February 26, 2020): 540. https:\/\/doi.org\/10.3390\/cells9030540<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][et_pb_toggle title=”PUBLICATIONS 2019″ open_toggle_text_color=”#5EC7ED” open_toggle_background_color=”#ffffff” closed_toggle_text_color=”#505659″ closed_toggle_background_color=”#AEE3F6″ icon_color=”#505659″ open_icon_color=”#505659″ _builder_version=”4.16″ _module_preset=”default” title_text_color=”#505659″ title_font=”|600||on|||||” title_text_align=”center” title_font_size=”22px” closed_title_text_align=”center” closed_title_font_size=”22px” body_text_align=”left” body_text_color=”#505659″ body_font_size=”16px” text_orientation=”center” global_colors_info=”{}”]<\/p>\n

\n\n\t\t7813506<\/span>\n\t\t<\/span>\n\t\tVDZ48X5N<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t2019<\/span>\n <\/span>\n items<\/span>\n\t\t1<\/span>\n\t\tchicago-fullnote-bibliography<\/span>\n\t\t0<\/span>\n\t\tdate<\/span>\n\t\tdesc<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n\t\t<\/span>\n <\/span>\n 36090<\/span>\n\t\thttps:\/\/www.crct-inserm.fr\/wp-content\/plugins\/zotpress\/<\/span>\n\n\t\t
\n\t\t\t
\n\t\t\t\t%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-19af25e8280dd7a93fdd9c1a774e1923%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22V2QHT6RD%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22M%5Cu00fcller%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EM%26%23xFC%3Bller%2C%20David%2C%20Sauyeun%20Shin%2C%20Th%26%23xE9%3Bo%20Goullet%20de%20Rugy%2C%20R%26%23xE9%3Bmi%20Samain%2C%20Romain%20Baer%2C%20Manon%20Strehaiano%2C%20Laia%20Masvidal-Sanz%2C%20et%20al.%20%26%23x201C%3BEIF4A%20Inhibition%20Circumvents%20Uncontrolled%20DNA%20Replication%20Mediated%20by%204E-BP1%20Loss%20in%20Pancreatic%20Cancer.%26%23x201D%3B%20%3Ci%3EJCI%20Insight%3C%5C%2Fi%3E%204%2C%20no.%2021%20%28November%201%2C%202019%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.121951%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2Fjci.insight.121951%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22eIF4A%20inhibition%20circumvents%20uncontrolled%20DNA%20replication%20mediated%20by%204E-BP1%20loss%20in%20pancreatic%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22M%5Cu00fcller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sauyeun%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Th%5Cu00e9o%22%2C%22lastName%22%3A%22Goullet%20de%20Rugy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9mi%22%2C%22lastName%22%3A%22Samain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Baer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Strehaiano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laia%22%2C%22lastName%22%3A%22Masvidal-Sanz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Guillermet-Guibert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshinori%22%2C%22lastName%22%3A%22Tsukumo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nahum%22%2C%22lastName%22%3A%22Sonenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Marion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Guilbaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Hoffmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ola%22%2C%22lastName%22%3A%22Larsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%5D%2C%22abstractNote%22%3A%22Pancreatic%20ductal%20adenocarcinoma%20%28PDAC%29%20relies%20on%20hyperactivated%20protein%20synthesis.%20Consistently%2C%20human%20and%20mouse%20PDAC%20lose%20expression%20of%20the%20translational%20repressor%20and%20mTOR%20target%204E-BP1.%20Using%20genome-wide%20polysome%20profiling%2C%20we%20here%20explore%20mRNAs%20whose%20translational%20efficiencies%20depend%20on%20the%20mTOR%5C%2F4E-BP1%20axis%20in%20pancreatic%20cancer%20cells.%20We%20identified%20a%20functional%20enrichment%20for%20mRNAs%20encoding%20DNA%20replication%20and%20repair%20proteins%2C%20including%20RRM2%20and%20CDC6.%20Consequently%2C%204E-BP1%20depletion%20favors%20DNA%20repair%20and%20renders%20DNA%20replication%20insensitive%20to%20mTOR%20inhibitors%2C%20in%20correlation%20with%20a%20sustained%20protein%20expression%20of%20CDC6%20and%20RRM2%2C%20which%20is%20inversely%20correlated%20with%204E-BP1%20expression%20in%20PDAC%20patient%20samples.%20DNA%20damage%20and%20pancreatic%20lesions%20induced%20by%20an%20experimental%20pancreatitis%20model%20uncover%20that%204E-BP1%5C%2F2-deleted%20mice%20display%20an%20increased%20acinar%20cell%20proliferation%20and%20a%20better%20recovery%20than%20WT%20animals.%20Targeting%20translation%2C%20independently%20of%204E-BP1%20status%2C%20using%20eIF4A%20RNA%20helicase%20inhibitors%20%28silvestrol%20derivatives%29%20selectively%20modulates%20translation%20and%20limits%20CDC6%20expression%20and%20DNA%20replication%2C%20leading%20to%20reduced%20PDAC%20tumor%20growth.%20In%20summary%2C%204E-BP1%20expression%20loss%20during%20PDAC%20development%20induces%20selective%20changes%20in%20translation%20of%20mRNA%20encoding%20DNA%20replication%20and%20repair%20protein.%20Importantly%2C%20targeting%20protein%20synthesis%20by%20eIF4A%20inhibitors%20circumvents%20PDAC%20resistance%20to%20mTOR%20inhibition.%22%2C%22date%22%3A%22Nov%2001%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1172%5C%2Fjci.insight.121951%22%2C%22ISSN%22%3A%222379-3708%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22PKLPPQDF%22%2C%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22NLRJ3GBL%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fuchs%20et%20al.%22%2C%22parsedDate%22%3A%222019-04-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFuchs%2C%20Steffen%2C%20Julian%20Naderi%2C%20and%20Fabienne%20Meggetto.%20%26%23x201C%3BNon-Coding%20RNA%20Networks%20in%20ALK-Positive%20Anaplastic-Large%20Cell%20Lymphoma.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Molecular%20Sciences%3C%5C%2Fi%3E%2020%2C%20no.%209%20%28April%2030%2C%202019%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms20092150%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms20092150%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Non-Coding%20RNA%20Networks%20in%20ALK-Positive%20Anaplastic-Large%20Cell%20Lymphoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steffen%22%2C%22lastName%22%3A%22Fuchs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julian%22%2C%22lastName%22%3A%22Naderi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22Non-coding%20RNAs%20%28ncRNAs%29%20are%20essential%20regulators%20of%20gene%20expression.%20In%20recent%20years%2C%20it%20has%20become%20more%20and%20more%20evident%20that%20the%20different%20classes%20of%20ncRNAs%2C%20such%20as%20micro%20RNAs%2C%20long%20non-coding%20RNAs%20and%20circular%20RNAs%20are%20organized%20in%20tightly%20controlled%20networks.%20It%20has%20been%20suggested%20that%20deregulation%20of%20these%20networks%20can%20lead%20to%20disease.%20Several%20studies%20show%20a%20contribution%20of%20these%20so-called%20competing-endogenous%20RNA%20networks%20in%20various%20cancer%20entities.%20In%20this%20review%2C%20we%20highlight%20the%20involvement%20of%20ncRNA%20networks%20in%20anaplastic-large%20cell%20lymphoma%20%28ALCL%29%2C%20a%20T-cell%20neoplasia.%20A%20majority%20of%20ALCL%20cases%20harbor%20the%20molecular%20hallmark%20of%20this%20disease%2C%20a%20fusion%20of%20the%20anaplastic%20lymphoma%20kinase%20%28ALK%29%20gene%20with%20the%20nucleophosmin%20%28NPM%2C%20NPM1%29%20gene%20leading%20to%20a%20permanently%20active%20kinase%20that%20promotes%20the%20malignant%20phenotype.%20We%20have%20focused%20especially%20on%20ncRNAs%20that%20are%20regulated%20by%20the%20NPM-ALK%20fusion%20gene%20and%20illustrate%20how%20their%20deregulation%20contributes%20to%20the%20pathogenesis%20of%20ALCL.%20Lastly%2C%20we%20summarize%20the%20findings%20and%20point%20out%20potential%20therapeutic%20implications.%22%2C%22date%22%3A%22Apr%2030%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms20092150%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A13Z%22%7D%7D%2C%7B%22key%22%3A%222NIFKM88%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoareau-Aveilla%20et%20al.%22%2C%22parsedDate%22%3A%222019-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHoareau-Aveilla%2C%20Coralie%2C%20Cathy%20Quelen%2C%20Annabelle%20Congras%2C%20Nina%20Caillet%2C%20Delphine%20Labourdette%2C%20Christine%20Dozier%2C%20Pierre%20Brousset%2C%20Laurence%20Lamant%2C%20and%20Fabienne%20Meggetto.%20%26%23x201C%3BMiR-497%20Suppresses%20Cycle%20Progression%20through%20an%20Axis%20Involving%20CDK6%20in%20ALK-Positive%20Cells.%26%23x201D%3B%20%3Ci%3EHaematologica%3C%5C%2Fi%3E%20104%2C%20no.%202%20%28February%202019%29%3A%20347%26%23x2013%3B59.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3324%5C%2Fhaematol.2018.195131%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3324%5C%2Fhaematol.2018.195131%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22miR-497%20suppresses%20cycle%20progression%20through%20an%20axis%20involving%20CDK6%20in%20ALK-positive%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Coralie%22%2C%22lastName%22%3A%22Hoareau-Aveilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%22%2C%22lastName%22%3A%22Quelen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Congras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nina%22%2C%22lastName%22%3A%22Caillet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delphine%22%2C%22lastName%22%3A%22Labourdette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Dozier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Brousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Lamant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabienne%22%2C%22lastName%22%3A%22Meggetto%22%7D%5D%2C%22abstractNote%22%3A%22Anaplastic%20large-cell%20lymphoma%2C%20a%20T-cell%20neoplasm%2C%20is%20primarily%20a%20pediatric%20disease.%20Seventy-five%20percent%20of%20pediatric%20anaplastic%20large-cell%20lymphoma%20cases%20harbor%20the%20chromosomal%20translocation%20t%282%3B5%29%28p23%3Bq35%29%20leading%20to%20the%20ectopic%20expression%20of%20NPM-ALK%2C%20a%20chimeric%20tyrosine%20kinase.%20NPM-ALK%20consists%20of%20an%20N-terminal%20nucleophosmin%20%28NPM%29%20domain%20fused%20to%20an%20anaplastic%20lymphoma%20kinase%20%28ALK%29%20cytoplasmic%20domain.%20Pediatric%20NPM-ALK%2B%20anaplastic%20large-cell%20lymphoma%20is%20often%20a%20disseminated%20disease%20and%20young%20patients%20are%20prone%20to%20chemoresistance%20or%20relapse%20shortly%20after%20chemotherapeutic%20treatment.%20Furthermore%2C%20there%20is%20no%20gold%20standard%20protocol%20for%20the%20treatment%20of%20relapses.%20To%20the%20best%20of%20our%20knowledge%2C%20this%20is%20the%20first%20study%20on%20the%20potential%20role%20of%20the%20microRNA%2C%20miR-497%2C%20in%20NPM-ALK%2B%20anaplastic%20large-cell%20lymphoma%20tumorigenesis.%20Our%20results%20show%20that%20miR-497%20expression%20is%20repressed%20in%20NPM-ALK%2B%20cell%20lines%20and%20patient%20samples%20through%20the%20hypermethylation%20of%20its%20promoter%20and%20the%20activity%20of%20NPM-ALK%20is%20responsible%20for%20this%20epigenetic%20repression.%20We%20demonstrate%20that%20overexpression%20of%20miR-497%20in%20human%20NPM-ALK%2B%20anaplastic%20large-cell%20lymphoma%20cells%20inhibits%20cellular%20growth%20and%20causes%20cell%20cycle%20arrest%20by%20targeting%20CDK6%2C%20E2F3%20and%20CCNE1%2C%20the%20three%20regulators%20of%20the%20G1%20phase%20of%20the%20cell%20cycle.%20Interestingly%2C%20we%20show%20that%20a%20scoring%20system%20based%20on%20CDK6%2C%20E2F3%20and%20CCNE1%20expression%20could%20help%20to%20identify%20relapsing%20pediatric%20patients.%20In%20addition%2C%20we%20demonstrate%20the%20sensitivity%20of%20NPM-ALK%2B%20cells%20to%20CDK4%5C%2F6%20inhibition%20using%20for%20the%20first%20time%20a%20selective%20inhibitor%2C%20palbociclib.%20Together%2C%20our%20findings%20suggest%20that%20CDK6%20could%20be%20a%20therapeutic%20target%20for%20the%20development%20of%20future%20treatments%20for%20NPM-ALK%2B%20anaplastic%20large-cell%20lymphoma.%22%2C%22date%22%3A%22Feb%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3324%5C%2Fhaematol.2018.195131%22%2C%22ISSN%22%3A%221592-8721%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-10-11T11%3A43%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22BI4RGEXL%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaud%20et%20al.%22%2C%22parsedDate%22%3A%222019-01-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJaud%2C%20Manon%2C%20C%26%23xE9%3Bline%20Philippe%2C%20Loic%20Van%20Den%20Berghe%2C%20Christ%26%23xE8%3Ble%20S%26%23xE9%3Bgura%2C%20Laurent%20Mazzolini%2C%20St%26%23xE9%3Bphane%20Pyronnet%2C%20Henrik%20Laurell%2C%20and%20Christian%20Touriol.%20%26%23x201C%3BThe%20PERK%20Branch%20of%20the%20Unfolded%20Protein%20Response%20Promotes%20DLL4%20Expression%20by%20Activating%20an%20Alternative%20Translation%20Mechanism.%26%23x201D%3B%20%3Ci%3ECancers%3C%5C%2Fi%3E%2011%2C%20no.%202%20%28January%2025%2C%202019%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers11020142%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fcancers11020142%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20PERK%20Branch%20of%20the%20Unfolded%20Protein%20Response%20Promotes%20DLL4%20Expression%20by%20Activating%20an%20Alternative%20Translation%20Mechanism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Jaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Philippe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loic%22%2C%22lastName%22%3A%22Van%20Den%20Berghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christ%5Cu00e8le%22%2C%22lastName%22%3A%22S%5Cu00e9gura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Mazzolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Laurell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Touriol%22%7D%5D%2C%22abstractNote%22%3A%22Delta-like%204%20%28DLL4%29%20is%20a%20pivotal%20endothelium%20specific%20Notch%20ligand%20that%20has%20been%20shown%20to%20function%20as%20a%20regulating%20factor%20during%20physiological%20and%20pathological%20angiogenesis.%20DLL4%20functions%20as%20a%20negative%20regulator%20of%20angiogenic%20branching%20and%20sprouting.%20Interestingly%2C%20Dll4%20is%20with%20Vegf-a%20one%20of%20the%20few%20examples%20of%20haplo-insufficiency%2C%20resulting%20in%20obvious%20vascular%20abnormalities%20and%20in%20embryonic%20lethality.%20These%20striking%20phenotypes%20are%20a%20proof%20of%20concept%20of%20the%20crucial%20role%20played%20by%20the%20bioavailability%20of%20VEGF%20and%20DLL4%20during%20vessel%20patterning%20and%20that%20there%20must%20be%20a%20very%20fine-tuning%20of%20DLL4%20expression%20level.%20However%2C%20to%20date%20the%20expression%20regulation%20of%20this%20factor%20was%20poorly%20studied.%20In%20this%20study%2C%20we%20showed%20that%20the%20DLL4%205%27-UTR%20harbors%20an%20Internal%20Ribosomal%20Entry%20Site%20%28IRES%29%20that%2C%20in%20contrast%20to%20cap-dependent%20translation%2C%20was%20efficiently%20utilized%20in%20cells%20subjected%20to%20several%20stresses%20including%20hypoxia%20and%20endoplasmic%20reticulum%20stress%20%28ER%20stress%29.%20We%20identified%20PERK%2C%20a%20kinase%20activated%20by%20ER%20stress%2C%20as%20the%20driver%20of%20DLL4%20IRES-mediated%20translation%2C%20and%20hnRNP-A1%20as%20an%20IRES-Trans-Acting%20Factor%20%28ITAF%29%20participating%20in%20the%20IRES-dependent%20translation%20of%20DLL4%20during%20endoplasmic%20reticulum%20stress.%20The%20presence%20of%20a%20stress%20responsive%20internal%20ribosome%20entry%20site%20in%20the%20DLL4%20msRNA%20suggests%20that%20the%20process%20of%20alternative%20translation%20initiation%2C%20by%20controlling%20the%20expression%20of%20this%20factor%2C%20could%20have%20a%20crucial%20role%20in%20the%20control%20of%20endothelial%20tip%20cell%20function.%22%2C%22date%22%3A%22Jan%2025%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fcancers11020142%22%2C%22ISSN%22%3A%222072-6694%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A22%3A58Z%22%7D%7D%2C%7B%22key%22%3A%22E2UBKDGT%22%2C%22library%22%3A%7B%22id%22%3A7813506%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alard%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAlard%2C%20Amandine%2C%20Catherine%20Marboeuf%2C%20Bertrand%20Fabre%2C%20Christine%20Jean%2C%20Yvan%20Martineau%2C%20Fr%26%23xE9%3Bd%26%23xE9%3Bric%20Lopez%2C%20Patrice%20Vende%2C%20et%20al.%20%26%23x201C%3BDifferential%20Regulation%20of%20the%20Three%20Eukaryotic%20MRNA%20Translation%20Initiation%20Factor%20%28EIF%29%204Gs%20by%20the%20Proteasome.%26%23x201D%3B%20%3Ci%3EFrontiers%20in%20Genetics%3C%5C%2Fi%3E%2010%20%282019%29%3A%20254.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffgene.2019.00254%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffgene.2019.00254%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Differential%20Regulation%20of%20the%20Three%20Eukaryotic%20mRNA%20Translation%20Initiation%20Factor%20%28eIF%29%204Gs%20by%20the%20Proteasome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amandine%22%2C%22lastName%22%3A%22Alard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Marboeuf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Fabre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Jean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvan%22%2C%22lastName%22%3A%22Martineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Lopez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrice%22%2C%22lastName%22%3A%22Vende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Poncet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20J.%22%2C%22lastName%22%3A%22Schneider%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Bousquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Pyronnet%22%7D%5D%2C%22abstractNote%22%3A%22The%204G%20family%20of%20eukaryotic%20mRNA%20translation%20initiation%20factors%20is%20composed%20of%20three%20members%20%28eIF4GI%2C%20eIF4GII%2C%20and%20DAP5%29.%20Their%20specific%20roles%20in%20translation%20initiation%20are%20under%20intense%20investigations%2C%20but%20how%20their%20respective%20intracellular%20amounts%20are%20controlled%20remains%20poorly%20understood.%20Here%20we%20show%20that%20eIF4GI%20and%20eIF4GII%20exhibit%20much%20shorter%20half-lives%20than%20that%20of%20DAP5.%20Both%20eIF4GI%20and%20eIF4GII%20proteins%2C%20but%20not%20DAP5%2C%20contain%20computer-predicted%20PEST%20motifs%20in%20their%20N-termini%20conserved%20across%20the%20animal%20kingdom.%20They%20are%20both%20sensitive%20to%20degradation%20by%20the%20proteasome.%20Under%20normal%20conditions%2C%20eIF4GI%20and%20eIF4GII%20are%20protected%20from%20proteasomal%20destruction%20through%20binding%20to%20the%20detoxifying%20enzyme%20NQO1%20%5BNAD%28P%29H%3Aquinone%20oxidoreductase%5D.%20However%2C%20when%20cells%20are%20exposed%20to%20oxidative%20stress%20both%20eIF4GI%20and%20eIF4GII%2C%20but%20not%20DAP5%2C%20are%20degraded%20by%20the%20proteasome%20in%20an%20N-terminal-dependent%20manner%2C%20and%20cell%20viability%20is%20more%20compromised%20upon%20silencing%20of%20DAP5.%20These%20findings%20indicate%20that%20the%20three%20eIF4G%20proteins%20are%20differentially%20regulated%20by%20the%20proteasome%20and%20that%20persistent%20DAP5%20plays%20a%20role%20in%20cell%20survival%20upon%20oxidative%20stress.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffgene.2019.00254%22%2C%22ISSN%22%3A%221664-8021%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NPEV4ECN%22%2C%22VDZ48X5N%22%5D%2C%22dateModified%22%3A%222021-04-26T15%3A23%3A10Z%22%7D%7D%5D%7D<\/span>\n\n\t\t\t\t
\n
\n
Müller, David, Sauyeun Shin, Théo Goullet de Rugy, Rémi Samain, Romain Baer, Manon Strehaiano, Laia Masvidal-Sanz, et al. “EIF4A Inhibition Circumvents Uncontrolled DNA Replication Mediated by 4E-BP1 Loss in Pancreatic Cancer.” JCI Insight<\/i> 4, no. 21 (November 1, 2019). https:\/\/doi.org\/10.1172\/jci.insight.121951<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Fuchs, Steffen, Julian Naderi, and Fabienne Meggetto. “Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma.” International Journal of Molecular Sciences<\/i> 20, no. 9 (April 30, 2019). https:\/\/doi.org\/10.3390\/ijms20092150<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Hoareau-Aveilla, Coralie, Cathy Quelen, Annabelle Congras, Nina Caillet, Delphine Labourdette, Christine Dozier, Pierre Brousset, Laurence Lamant, and Fabienne Meggetto. “MiR-497 Suppresses Cycle Progression through an Axis Involving CDK6 in ALK-Positive Cells.” Haematologica<\/i> 104, no. 2 (February 2019): 347–59. https:\/\/doi.org\/10.3324\/haematol.2018.195131<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Jaud, Manon, Céline Philippe, Loic Van Den Berghe, Christèle Ségura, Laurent Mazzolini, Stéphane Pyronnet, Henrik Laurell, and Christian Touriol. “The PERK Branch of the Unfolded Protein Response Promotes DLL4 Expression by Activating an Alternative Translation Mechanism.” Cancers<\/i> 11, no. 2 (January 25, 2019). https:\/\/doi.org\/10.3390\/cancers11020142<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\t\t\t\t
\n
\n
Alard, Amandine, Catherine Marboeuf, Bertrand Fabre, Christine Jean, Yvan Martineau, Frédéric Lopez, Patrice Vende, et al. “Differential Regulation of the Three Eukaryotic MRNA Translation Initiation Factor (EIF) 4Gs by the Proteasome.” Frontiers in Genetics<\/i> 10 (2019): 254. https:\/\/doi.org\/10.3389\/fgene.2019.00254<\/a>.<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\n

[\/et_pb_toggle][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”448e09ae-9652-4ead-bc5f-152c7adf1202″ global_colors_info=”{}”]<\/p>\n

LES MEMBRES DE L\u2019\u00c9QUIPE<\/strong><\/h2>\n

[\/et_pb_text][et_pb_divider color=”#F19532″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” max_width=”none” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

\n
<\/div>\n\n\n
\n
\n
\n
\n
\n
\"\"<\/a><\/div>\n
Guillaume Flandin<\/a><\/div>\n
Master \/ Master student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Sandra Dailhau<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Laurent Mazzolini<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Ahmed Zamani<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Chlo\u00e9 Bessiere<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Christian Touriol<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Laurence Lamant<\/a><\/div>\n
Enseignant chercheur \/ University researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
St\u00e9phane Pyronnet<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Fabienne Meggetto<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Alexandre Gay<\/a><\/div>\n
Ing\u00e9nieur de laboratoire \/ laboratory engineer<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Catherine Marboeuf<\/a><\/div>\n
Technicien de laboratoire \/ Laboratory Technician<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Eulalie Corre<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Elissa Andraos<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
C\u00e9cile Soum<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Romain Pfeifer<\/a><\/div>\n
Doctorant \/ PhD student<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Marina Bousquet<\/a><\/div>\n
Chercheur statutaire \/ permanent scientist<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Steffen Fuchs<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n
\n
\n
\"\"<\/a><\/div>\n
Lo\u00e9lia Babin<\/a><\/div>\n
Chercheur Post-Doctorant \/ Post-Doc researcher<\/div><\/div>\n<\/div><\/div><\/div> <\/div>\n <\/div>\n<\/div><\/div>\n\n
<\/div><\/div>\n\n